DANA-FARBER CANCER INSTITUTE: Form 990, tax year 2024

View the entire original 990 at ProPublica ↗

Organization: DANA-FARBER CANCER INSTITUTE (EIN 04-2263040)
Tax period: 2024-10-01 to 2025-09-30
Filed: 2026-07-28
IRS object ID: 202602099349300935
Schema version: 2024v5.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule H
Schedule I
Schedule J
Schedule K
Schedule K
Schedule L
Schedule M
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2026-07-28T16:45:39+00:00	ReturnTs
Tax Period End	2025-09-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	346565596	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	200 CLARENDON STREET	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	021165072	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2024-10-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	042263040	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	Dana-Farber Cancer Institute Inc	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Business Name Control	DANA	BusinessNameControlTxt
Phone	6176323000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVENUE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	MICHAEL L RENEY	PersonNm
Person Title	CFO & ASSISTANT TREASURER	PersonTitleTxt
Phone	6176323000	PhoneNum
Signature	2026-07-28	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	George Pagano	PreparerPersonNm
PTIN	P01978122	PTIN
Phone	6172662000	PhoneNum
Preparation	2026-07-24	PreparationDt

Field	Value	IRS element (for citing)
Tax	2024	TaxYr
Build TS	2025-03-06 01:10:19Z	BuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	BENJAMIN EBERT MD PHD PRESIDENT	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVENUE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$3,920,793,349	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.DANA-FARBER.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1951	FormationYr
Legal Domicile State	MA	LegalDomicileStateCd
Activity Or Mission	SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	66	VotingMembersGoverningBodyCnt
Voting Members Independent	65	VotingMembersIndependentCnt
Total Employee	9731	TotalEmployeeCnt
Total Volunteers	500	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$0	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$779,153,701	PYContributionsGrantsAmt
CY Contributions Grants	$775,180,377	CYContributionsGrantsAmt
PY Program Service Revenue	$2,611,491,064	PYProgramServiceRevenueAmt
CY Program Service Revenue	$3,030,902,186	CYProgramServiceRevenueAmt
PY Investment Income	$5,694,108	PYInvestmentIncomeAmt
CY Investment Income	$4,786,266	CYInvestmentIncomeAmt
PY Other Revenue	$75,255,837	PYOtherRevenueAmt
CY Other Revenue	$106,902,430	CYOtherRevenueAmt
PY Total Revenue	$3,471,594,710	PYTotalRevenueAmt
CY Total Revenue	$3,917,771,259	CYTotalRevenueAmt
PY Grants And Similar Paid	$7,580,997	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$8,197,302	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$1,082,475,984	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$1,212,731,474	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$5,632,350	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$5,624,710	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$55,757,821	CYTotalFundraisingExpenseAmt
PY Other Expenses	$2,262,455,426	PYOtherExpensesAmt
CY Other Expenses	$2,598,533,141	CYOtherExpensesAmt
PY Total Expenses	$3,358,144,757	PYTotalExpensesAmt
CY Total Expenses	$3,825,086,627	CYTotalExpensesAmt
PY Revenues Less Expenses	$113,449,953	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$92,684,632	CYRevenuesLessExpensesAmt
Total Assets BOY	$5,348,876,627	TotalAssetsBOYAmt
Total Assets EOY	$5,997,012,444	TotalAssetsEOYAmt
Total Liabilities BOY	$1,437,795,236	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$1,513,380,172	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$3,911,081,391	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$4,483,632,272	NetAssetsOrFundBalancesEOYAmt
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$2,583,812,037	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$3,030,902,186	RevenueAmt
Desc	CLINICAL CARE - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$835,998,547	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$0	RevenueAmt
Desc	RESEARCH - SEE SCHEDULE O	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$49,344,471	ExpenseAmt
Grant	$8,197,302	GrantAmt
Revenue	$0	RevenueAmt
Desc	COMMUNITY BENEFITS - SEE SCHEDULE O	Desc

Field	Value	IRS element (for citing)
Total Program Service Expenses	$3,469,155,055	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Donor Rstr Or Quasi Endowments	Yes (true)	DonorRstrOrQuasiEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	Yes (true)	ReportOtherAssetsInd
Report Other Liabilities	Yes (true)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	false	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	false	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (true)	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	false	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	Yes (true)	OperateHospitalInd
Audited Financial Stmt Att	Yes (true)	AuditedFinancialStmtAttInd
Grants To Organizations	Yes (true)	GrantsToOrganizationsInd
Grants To Individuals	Yes (true)	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	Yes (true)	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	false	BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent	false	BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri	Yes (true)	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	Yes (true)	DisregardedEntityInd
Related Entity	Yes (true)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (true)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (true)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	Yes (true)	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
Info In Schedule O Part V	Yes (X)	InfoInScheduleOPartVInd
IRP Document	1048	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	9731	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	Yes (true)	ForeignFinancialAccountInd
Foreign Country	KS	ForeignCountryCd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	Yes (true)	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	false	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	66	GoverningBodyVotingMembersCnt
Independent Voting Member	65	IndependentVotingMemberCnt
Family Or Business Rln	Yes (true)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	false	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Policies Reference Chapters	false	PoliciesReferenceChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
Written Policy Or Procedure	false	WrittenPolicyOrProcedureInd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	MELISSA CHAMMAS	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Phone	6176323000	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE BP418	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02115	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (89 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd	Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd
Benjamin Ebert MD PhD
TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24)	43.0	7.0	Yes (X)	Yes (X)	$468,091	$0	$63,424
JOSHUA BEKENSTEIN
Trustee & Chairman	2.0	3.0	Yes (X)	Yes (X)	$0	$0	$0
Lori Whelan
Trustee, Treasurer	2.0	3.0	Yes (X)	Yes (X)	$0	$0	$0
Monica Chandra
Trustee & Secretary	1.0	1.0	Yes (X)	Yes (X)	$0	$0	$0
Richard Lubin
Trustee & Vice-Chairman	2.0	0	Yes (X)	Yes (X)	$0	$0	$0
Afsaneh Beschloss
Trustee	1.0	0	Yes (X)		$0	$0	$0
Alison Jaffe
Trustee	1.0	0	Yes (X)		$0	$0	$0
Amy Berylson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Amy Kyle ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Andrew Janower
Trustee	1.0	0	Yes (X)		$0	$0	$0
Andrew Kaplan
Trustee	1.0	0	Yes (X)		$0	$0	$0
Beth Terrana
Trustee	1.0	0	Yes (X)		$0	$0	$0
Betty Ann Blum
Trustee	1.0	0	Yes (X)		$0	$0	$0
Bradley Lucas
Trustee	1.0	0	Yes (X)		$0	$0	$0
Brian Knez
Trustee	1.0	0	Yes (X)		$0	$0	$0
Christopher J Hadley
Trustee	1.0	0	Yes (X)		$0	$0	$0
Demond Martin
Trustee	1.0	0	Yes (X)		$0	$0	$0
Doug Grip
Trustee	1.0	0	Yes (X)		$0	$0	$0
Elizabeth Clymer
Trustee	1.0	0	Yes (X)		$0	$0	$0
Elizabeth Rappaport
Trustee (AS OF 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Eric Miller
Trustee	1.0	0	Yes (X)		$0	$0	$0
Esta Stecher
Trustee	1.0	0	Yes (X)		$0	$0	$0
Fatima Penrose
Trustee	1.0	0	Yes (X)		$0	$0	$0
Frank Laukien PHD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Frederica Williams
Trustee	1.0	0	Yes (X)		$0	$0	$0
Gary Prado
Trustee	1.0	0	Yes (X)		$0	$0	$0
Harvey Berger MD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Hise Gibson
Trustee	1.0	0	Yes (X)		$0	$0	$0
James McCann
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jane Brock-Wilson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jane Jamieson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jennifer Perini
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jessica Knez-Dulac
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jill Greenthal
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jodi Walker
Trustee	1.0	0	Yes (X)		$0	$0	$0
Jose Aguerrevere
Trustee	1.0	0	Yes (X)		$0	$0	$0
Karen Daley PHD MPH RN FANN
Trustee	1.0	0	Yes (X)		$0	$0	$0
Karen Linde Packman
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kate Gulliver
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kenneth Lochiatto
Trustee (AS OF 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Kevin DaSilva
Trustee	1.0	0	Yes (X)		$0	$0	$0
Kimberly Sherman Stamler
Trustee	1.0	0	Yes (X)		$0	$0	$0
Laura Sen
Trustee	1.0	0	Yes (X)		$0	$0	$0
Levi Garraway MD PhD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Lisa Ferraro
Trustee	1.0	0	Yes (X)		$0	$0	$0
Louise Svanberg
Trustee	1.0	0	Yes (X)		$0	$0	$0
Meg Reynolds
Trustee	1.0	0	Yes (X)		$0	$0	$0
Michael Eisenson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Michael Trotsky
Trustee	1.0	0	Yes (X)		$0	$0	$0
Moria Forbes
Trustee (END 9/22/25)	1.0	0	Yes (X)		$0	$0	$0
Nancy Gibson
Trustee	1.0	0	Yes (X)		$0	$0	$0
Nancy Lotane
Trustee	1.0	0	Yes (X)		$0	$0	$0
Paul Marcus
Trustee	1.0	0	Yes (X)		$0	$0	$0
Payal Divakaran
Trustee (AS OF 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Peter Palandjian
Trustee	1.0	0	Yes (X)		$0	$0	$0
Phillip Gross
Trustee	1.0	0	Yes (X)		$0	$0	$0
Robert Reynolds
Trustee	1.0	0	Yes (X)		$0	$0	$0
Robert Stansky
Trustee	1.0	0	Yes (X)		$0	$0	$0
Ronald Sullivan
Trustee	1.0	0	Yes (X)		$0	$0	$0
Sandra Stratford MD
Trustee	1.0	0	Yes (X)		$0	$0	$0
Stephen Koster ESQ
Trustee (END 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Steven Koppel
Trustee	1.0	0	Yes (X)		$0	$0	$0
Susan Alexander ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
Susan Poduska
Trustee	1.0	0	Yes (X)		$0	$0	$0
Sushil Tuli
Trustee	1.0	0	Yes (X)		$0	$0	$0
Theodore Pasquarello
Trustee (END 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Timothy Cohen
Trustee	1.0	0	Yes (X)		$0	$0	$0
Tracey McCain ESQ
Trustee	1.0	0	Yes (X)		$0	$0	$0
William Santis MD
Trustee (AS OF 1/27/25)	1.0	0	Yes (X)		$0	$0	$0
Jennifer Willcox ESQ
Asst Secretary & General Counsel	50.0	0		Yes (X)	$872,309	$0	$85,729
Michael L Reney
CFO & Assistant Treasurer	46.0	4.0		Yes (X)	$1,217,752	$0	$52,171
William Hahn MD PHD
COO & EVP	49.0	1.0		Yes (X)	$1,453,272	$0	$52,093
Barrett J Rollins MD PHD
Sr. Advisor to President & CEO	50.0	0			$565,346	$0	$60,362	Yes (X)
Craig A Bunnell MD MPH MBA
Chief Medical Officer	50.0	0			$1,066,683	$0	$89,863	Yes (X)
Jeffrey Meyerhardt MD MPH
Chief Clinical Research Officer	48.0	2.0			$752,787	$0	$92,059	Yes (X)
Kevin Haigis PHD
Chief Scientific Officer	50.0	0			$691,806	$0	$52,050	Yes (X)
Maria Megdal
SVP Chief Administrative Officer	50.0	0			$649,630	$0	$107,407	Yes (X)
Melany Duval
SVP & Chief Philanthropy Officer	50.0	0			$1,154,110	$0	$71,100	Yes (X)
Naomi Lenane
SVP INFORMATION SERVICES CIO	50.0	0			$169,338	$0	$29,312	Yes (X)
Patrick McCormick
SVP HOSPITAL TRANSFORMATION	50.0	0			$394,169	$0	$10,879	Yes (X)
Sylvia A Bartel RPh MHP
SR. VP of Pharmacy & CPO	50.0	0			$374,157	$0	$88,635	Yes (X)
Wendy Gettleman
VP of Facilities Management & Real Estate	50.0	0			$400,510	$0	$91,933	Yes (X)
George D Demetri MD
PROFESSOR	50.0	0			$781,464	$0	$72,016		Yes (X)
Laurie H Glimcher MD
President & CEO Emerita	50.0	0.0			$2,313,019	$0	$366,631		Yes (X)
Michael Constantine MD
Milford Med Dir-Hematology/Oncology	50.0	0			$831,650	$0	$93,119		Yes (X)
Robert Soiffer MD
Chief Clinical Program Officer	50.0	0			$882,186	$0	$71,734		Yes (X)
Scott Armstrong MD PHD
Chair of Pediatric Oncology	50.0	0			$843,326	$0	$84,542		Yes (X)
Bruce Johnson MD
Former	0.0	0			$290,667	$0	$42,086			Yes (X)
John O Chesley ESQ
Former Officer	0.0	0			$417,532	$0	$172			Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$16,589,804	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$1,677,317	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	2997	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	Yes (true)	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
BRIGHAM AND WOMEN'S HOSPITAL
399 Revolution Drive Ste 645	SOMERVILLE	MA	02145	MEDICAL SERVICES	$232,320,543
CARDINAL HEALTH
7611 Brandon Woods Blvd	Baltimore	MD	21226	MEDICAL SERVICES	$68,336,278
South Shore Hospital
55 Fogg Rd South	Weymouth	MA	02190	Medical Services	$37,936,394
Advanced Accelerator Applications USA Inc
350 Fifth Avenue	New York	NY	10118	Radiotherapy	$28,320,273
WALSH BROTHERS INC
200 COMMERCIAL ST	BOSTON	MA	02109	BUILDING CONTRACTOR	$17,494,540

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	686	CntrctRcvdGreaterThan100KCnt
Federated Campaigns	$109,974	FederatedCampaignsAmt
Fundraising	$17,154,286	FundraisingAmt
Related Organizations	$1,340,898	RelatedOrganizationsAmt
Government Grants	$187,288,946	GovernmentGrantsAmt
All Other Contributions	$569,286,273	AllOtherContributionsAmt
Noncash Contributions	$31,139,415	NoncashContributionsAmt
Total Contributions	$775,180,377	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
NET PATIENT SERVICE REVENUE	621110	$3,014,499,786	$3,014,499,786
NETWORK COLLABORATION	900099	$12,681,408	$12,681,408
LINAC	621500	$3,720,992	$3,720,992

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$3,030,902,186	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$4,786,266	TotalRevenueColumnAmt
Exclusion	$4,786,266	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$88,911,113	TotalRevenueColumnAmt
Exclusion	$88,911,113	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$1,419,015	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$1,419,015	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,419,015	TotalRevenueColumnAmt
Exclusion	$1,419,015	ExclusionAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$0	SecuritiesAmt
Other	$0	OtherAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$572,369	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$17,154,286	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$3,022,090	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$2,449,721	TotalRevenueColumnAmt
Exclusion	-$2,449,721	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt
FOOD SERVICE REVENUE	722514	$5,775,906	$5,775,906
PARKING LOT REVENUE	812930	$5,063,047	$5,063,047
Surplus Capital Distribution	524298	$4,005,132	$4,005,132

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$4,177,938	TotalRevenueColumnAmt
Related Or Exempt Func Income	$0	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$4,177,938	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$19,022,023	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,917,771,259	TotalRevenueColumnAmt
Related Or Exempt Func Income	$3,030,902,186	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$111,688,696	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$4,518,181	TotalAmt
Program Services	$4,518,181	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$3,679,121	TotalAmt
Program Services	$3,679,121	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$10,229,960	TotalAmt
Program Services	$3,450,779	ProgramServicesAmt
Management And General	$5,625,071	ManagementAndGeneralAmt
Fundraising	$1,154,110	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$3,021,218	TotalAmt
Program Services	$290,667	ProgramServicesAmt
Management And General	$2,730,551	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$949,518,738	TotalAmt
Program Services	$798,430,669	ProgramServicesAmt
Management And General	$118,340,857	ManagementAndGeneralAmt
Fundraising	$32,747,212	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$61,957,100	TotalAmt
Program Services	$51,622,155	ProgramServicesAmt
Management And General	$8,153,294	ManagementAndGeneralAmt
Fundraising	$2,181,651	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$121,441,680	TotalAmt
Program Services	$101,184,227	ProgramServicesAmt
Management And General	$15,907,202	ManagementAndGeneralAmt
Fundraising	$4,350,251	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$66,562,778	TotalAmt
Program Services	$55,459,569	ProgramServicesAmt
Management And General	$8,759,382	ManagementAndGeneralAmt
Fundraising	$2,343,827	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$6,147,923	TotalAmt
Program Services	$5,185,353	ProgramServicesAmt
Management And General	$962,570	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$20,276,028	TotalAmt
Program Services	$10,916,885	ProgramServicesAmt
Management And General	$9,350,230	ManagementAndGeneralAmt
Fundraising	$8,913	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$922,472	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$922,472	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$1,128,432	TotalAmt
Program Services	$1,128,432	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$5,624,710	TotalAmt
Fundraising	$5,624,710	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$131,522,532	TotalAmt
Program Services	$100,290,367	ProgramServicesAmt
Management And General	$30,184,854	ManagementAndGeneralAmt
Fundraising	$1,047,311	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$16,565,913	TotalAmt
Program Services	$10,181,658	ProgramServicesAmt
Management And General	$4,839,898	ManagementAndGeneralAmt
Fundraising	$1,544,357	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$14,842,682	TotalAmt
Program Services	$9,197,461	ProgramServicesAmt
Management And General	$4,165,101	ManagementAndGeneralAmt
Fundraising	$1,480,120	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$96,972,569	TotalAmt
Program Services	$88,049,849	ProgramServicesAmt
Management And General	$8,767,639	ManagementAndGeneralAmt
Fundraising	$155,081	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$174,982,892	TotalAmt
Program Services	$148,634,938	ProgramServicesAmt
Management And General	$26,345,798	ManagementAndGeneralAmt
Fundraising	$2,156	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$13,285,255	TotalAmt
Program Services	$12,167,227	ProgramServicesAmt
Management And General	$957,091	ManagementAndGeneralAmt
Fundraising	$160,937	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$7,141,445	TotalAmt
Program Services	$2,642,956	ProgramServicesAmt
Management And General	$2,931,666	ManagementAndGeneralAmt
Fundraising	$1,566,823	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$23,244,440	TotalAmt
Program Services	$22,742,170	ProgramServicesAmt
Management And General	$502,270	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$98,740,404	TotalAmt
Program Services	$83,319,822	ProgramServicesAmt
Management And General	$15,420,582	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$9,522,081	TotalAmt
Program Services	$8,663	ProgramServicesAmt
Management And General	$9,513,418	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PHARMACEUTICALS	$1,606,226,432	$1,606,226,432	$0	$0
Medical Supplies Expense	$155,112,717	$154,746,233	$366,484	$0
OTHER PATIENT CARE EXPENSE	$49,831,525	$49,831,525	$0	$0
BAD DEBT EXPENSE	$1,646,424	$1,646,424	$0	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$170,420,975	TotalAmt
Program Services	$143,603,292	ProgramServicesAmt
Management And General	$25,427,321	ManagementAndGeneralAmt
Fundraising	$1,390,362	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$3,825,086,627	TotalAmt
Program Services	$3,469,155,055	ProgramServicesAmt
Management And General	$300,173,751	ManagementAndGeneralAmt
Fundraising	$55,757,821	FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$81,120,933	BOYAmt
EOY	$121,275,037	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$81,609,743	BOYAmt
EOY	$70,592,422	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$338,818,104	BOYAmt
EOY	$343,804,929	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$488,479	BOYAmt
EOY	$951,018	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$87,864,118	BOYAmt
EOY	$105,877,230	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$137,272,053	BOYAmt
EOY	$158,869,947	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$2,383,471,357	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$1,294,235,552	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$985,863,110	BOYAmt
EOY	$1,089,235,805	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$7,894,580	BOYAmt
EOY	$7,894,580	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$3,627,945,507	BOYAmt
EOY	$4,098,511,476	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$5,348,876,627	BOYAmt
EOY	$5,997,012,444	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$253,302,762	BOYAmt
EOY	$281,073,287	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$479,709,000	BOYAmt
EOY	$472,286,000	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$67,364,000	BOYAmt
EOY	$65,255,000	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$637,419,474	BOYAmt
EOY	$694,765,885	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$1,437,795,236	BOYAmt
EOY	$1,513,380,172	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows FASB117	Yes (X)	OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$2,005,198,802	BOYAmt
EOY	$2,368,122,196	EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$1,905,882,589	BOYAmt
EOY	$2,115,510,076	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$3,911,081,391	BOYAmt
EOY	$4,483,632,272	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$5,348,876,627	BOYAmt
EOY	$5,997,012,444	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$92,684,632	ReconcilationRevenueExpnssAmt
Other Changes In Net Assets	$479,866,249	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$726,297,460	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$702,430,542	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$761,032,475	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$779,153,701	CurrentTaxYearMinus1YearAmt
Current Tax Year	$775,180,377	CurrentTaxYearAmt
Total	$3,744,094,555	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$726,297,460	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$702,430,542	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$761,032,475	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$779,153,701	CurrentTaxYearMinus1YearAmt
Current Tax Year	$775,180,377	CurrentTaxYearAmt
Total	$3,744,094,555	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$0	SubstantialContributorsTotAmt
Public Support Total170	$3,744,094,555	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$113,415,703	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$44,851,524	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$334,501,187	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$70,209,024	CurrentTaxYearMinus1YearAmt
Current Tax Year	$95,116,394	CurrentTaxYearAmt
Total	$658,093,832	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$93,395	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$65,661	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$0	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$41,707	CurrentTaxYearMinus1YearAmt
Current Tax Year	$0	CurrentTaxYearAmt
Total	$200,763	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$7,706,225	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$13,596,972	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$16,868,465	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$14,507,380	CurrentTaxYearMinus1YearAmt
Current Tax Year	$19,594,390	CurrentTaxYearAmt
Total	$72,273,432	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$4,474,662,582	TotalSupportAmt
Gross Receipts Rltd Activities	$11,404,818,951	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.83673	PublicSupportCY170Pct
Public Support PY170	0.84037	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule A, Part II, Line 10 Other Income	FormAndLineReferenceDesc
Explanation	DESCRIPTION - PARKING LOT REVENUE, COLUMN A - 3167144.0, COLUMN B - 4721708.0, COLUMN C - 4855402.0, COLUMN D - 4997539.0, COLUMN E - 5063047.0, COLUMN F - 22804840.0; DESCRIPTION - FOOD SERVICE REVENUE, COLUMN A - 2516332.0, COLUMN B - 3633966.0, COLUMN C - 4388191.0, COLUMN D - 5102880.0, COLUMN E - 5775906.0, COLUMN F - 21417275.0; DESCRIPTION - SURPLUS CAPITAL DISTRIBUTION, COLUMN A - 0.0, COLUMN B - 1820768.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 4005129.0, COLUMN F - 5825897.0; DESCRIPTION - MISCELLANOUS REVENUE, COLUMN A - 1067783.0, COLUMN B - 2815275.0, COLUMN C - 3125300.0, COLUMN D - 2921265.0, COLUMN E - 2613948.0, COLUMN F - 12543571.0; DESCRIPTION - FUNDRAISING EVENTS, COLUMN A - 256368.0, COLUMN B - 605255.0, COLUMN C - 499572.0, COLUMN D - 480682.0, COLUMN E - 572369.0, COLUMN F - 2414246.0; DESCRIPTION - DISTRIBUTION FROM DFMGBCC, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 4000000.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 4000000.0; DESCRIPTION - BOUTIQUE, COLUMN A - 698598.0, COLUMN B - 0.0, COLUMN C - 0.0, COLUMN D - 1005014.0, COLUMN E - 1563991.0, COLUMN F - 3267603.0;	ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	Yes (true)	VolunteersInd
Paid Staff Or Management	Yes (true)	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Mailings Members	false	MailingsMembersInd
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Grants Other Organizations	Yes (true)	GrantsOtherOrganizationsInd
Grants Other Organizations	$742,454	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$385,978	DirectContactLegislatorsAmt
Rallies Demonstrations	false	RalliesDemonstrationsInd
Other Activities	false	OtherActivitiesInd
Total Lobbying Expenditures	$1,128,432	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule C, Part II-B	FormAndLineReferenceDesc
Explanation	ALLIANCE OF DEDICATED CANCER CENTERS REPRESENTS THE NATION'S TEN FREESTANDING CANCER CENTERS. WE WORK TOGETHER ON FEDERAL REGULATORY, LEGISLATIVE, AND REIMBURSEMENT ISSUES UNIQUE TO DEDICATED CANCER CENTERS. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. ALSTON & BIRD LLP PROVIDED FEDERAL LEGISLATIVE CONSULTING FOR DFCI. DFCI IS A MEMBER OF THE AMERICAN HOSPITAL ASSOCIATION, A NOT-FOR-PROFIT ORGANIZATION THAT REPRESENTS AND ADVOCATES FOR THE COLLECTIVE INTERESTS OF THEIR MEMBERS THROUGH PUBLIC ADVOCACY, EDUCATION, AND INFORMATION. ON OCCASION, DFCI EXECUTIVE LEADERSHIP MEET WITH STATE AND FEDERAL ELECTED OFFICIALS TO ADVOCATE FOR THE PASSAGE OF LEGISLATION AND FUNDING TO ADVANCE CANCER RESEARCH AND TREATMENT, AND LEGISLATION TO SUPPORT SERVICES FOR CANCER PATIENTS AND CANCER SURVIVORS. IN ADDITION, DFCI SUBMITS LETTERS AND/OR TESTIMONY TO ELECTED OFFICIALS AND POLICY MAKERS ON THESE ISSUES. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. DFCI IS A MEMBER THE AMERICAN ASSOCIATION OF MEDICAL COLLEGES WHICH FOCUSES ON TRANSFORMING HEALTH CARE IN FOUR PRIMARY MISSION AREAS: MEDICIAL EDUCATION, BIOMEDICAL RESEARCH, CLINICAL CARE, AND COMMUNITY COLLABORATIONS. THEY ARE THE LEADING VOICE OF THE NATION'S MEDICAL SCHOOLS, ACADEMIC HEALTH SYSTEMS, AND ACADEMIC SOCIETIES WITH THE PUBLIC AND BEFORE CONGRESS, FEDERAL REGULATORY AGENCIES, AND THE EXECUTIVE BRANCH. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. CONFERENCE OF BOSTON TEACHING HOSPITALS PROVIDED STATE AND FEDERAL LOBBYING SUPPORT TO DFCI. CQ ROLL CALL PROVIDES GRASSROOTS ADVOCACY SOFTWARE USED FOR EMAILS AND ACTION ALERTS ON ADVOCACY ISSUES WHICH ARE SENT TO MEMBERS OF DANA-FARBER'S LEGISLATIVE ACTION NETWORK(LAN). DFCI'S LAN ADVOCATES FOR LEGISLATION AND POLICIES THAT IMPROVE THE LIVES OF CANCER PATIENTS. DFCI IS A MEMBER OF THE MASSACHUSETTS BUSINESS ROUNDTABLE WHICH IS A PUBLIC POLICY ORGANIZATION THAT HAS DONE EXETENSIVE POLICY WORK ON EDUCATION, HEALTH CARE, COMPETITIVENESS, WORKFORCE DEVELOPMENT, SOCIAL AND INFRATSTRUCTURE ISSUES THAT HAVE BROAD IMPACT ON THE SOCIAL AND ECONOMIC WELLBEING OF THE COMMONWEALTH. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. DFCI IS A MEMBER OF THE MASSACHUSETTS HEALTH AND HOSPITAL ASSOCIATION. THE MHA SERVES AS THE UNIFIED VOICE FOR THE COMMONWEALTH'S HOSPITALS, HEALTH SYSTEMS, AND HEALTHCARE PROVIDERS THROUGH ADVOCACY, INFORMATION AND EDUCATION, COLLABORATION. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. DFCI IS A MEMBER OF THE MASSACHUSETTS TAXPAYER FOUNDATION WHICH IS WIDELY RECOGNIZED AS THE STATE'S PREMIER PUBLIC POLICY ORGANIZATION DEALING WITH STATE AND LOCAL FISCAL, TAX, AND ECONOMIC POLICIES. A PORTION OF THE MEMBERSHIP DUES ARE USED FOR LOBBYING ACTIVITIES. MCDERMOTT, QUILTY, MILLER & HANLEY, LLP PROVIDED STATE LEGISLATIVE AND GOVERNMENT RELATIONS CONSULTING FOR DFCI. DFCI IS A MEMBER OF THE NEW ENGLAND COUNCIL WHICH IS A NON-PARTISAN ALLIANCE OF BUSINESSES, ACADEMIC AND HEALTH INSTITUTIONS, AND PUBLIC AND PRIVATE ORGANIZATIONS THROUGHOUT NEW ENGLAND FORMED TO PROMOTE GROWTH AND QUALITY OF LIFE IN THE NEW ENGLAND REGION; BY ARTICULATING THE VOICE REGIONALLY AND NATIONALLY ON F IMPORTANT ISSUES FACING NEW ENGLAND. TSK ASSOCIATES PROVIDES STATE LEGISLATIVE AND GOVERNMENT RELATIONS CONSULTING FOR DFCI.	ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$526,463,000	BeginningYearBalanceAmt
Contributions	$23,900,000	ContributionsAmt
Investment Earnings Or Losses	$74,620,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$30,589,000	OtherExpendituresAmt
End Year Balance	$594,394,000	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$458,787,000	BeginningYearBalanceAmt
Contributions	$21,098,000	ContributionsAmt
Investment Earnings Or Losses	$77,016,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$30,438,000	OtherExpendituresAmt
End Year Balance	$526,463,000	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$430,270,000	BeginningYearBalanceAmt
Contributions	$18,963,000	ContributionsAmt
Investment Earnings Or Losses	$38,462,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$28,908,000	OtherExpendituresAmt
End Year Balance	$458,787,000	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$479,196,000	BeginningYearBalanceAmt
Contributions	$29,347,000	ContributionsAmt
Investment Earnings Or Losses	-$55,371,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$22,902,000	OtherExpendituresAmt
End Year Balance	$430,270,000	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$357,421,000	BeginningYearBalanceAmt
Contributions	$14,528,000	ContributionsAmt
Investment Earnings Or Losses	$122,237,000	InvestmentEarningsOrLossesAmt
Other Expenditures	$14,990,000	OtherExpendituresAmt
End Year Balance	$479,196,000	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.0	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.582	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.418	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	Yes (true)	EndowmentsHeldRelatedOrgInd
Related Org List Sch R	Yes (true)	RelatedOrgListSchRInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$17,067,029	OtherCostOrOtherBasisAmt
Book Value	$17,067,029	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,388,362,740	OtherCostOrOtherBasisAmt
Depreciation	$812,421,711	DepreciationAmt
Book Value	$575,941,029	BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$401,353,204	OtherCostOrOtherBasisAmt
Depreciation	$198,115,730	DepreciationAmt
Book Value	$203,237,474	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$370,459,310	OtherCostOrOtherBasisAmt
Depreciation	$283,698,111	DepreciationAmt
Book Value	$86,761,199	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$206,229,074	OtherCostOrOtherBasisAmt
Book Value	$206,229,074	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$1,089,235,805	TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (4 entries)

DescDesc	Book ValueBookValueAmt
INTEREST IN DANA-FARBER, INC.	$3,554,753,508
RIGHT OF USE - NET OPERATING LEASES	$386,864,177
RESEARCH RECEIVABLES	$81,365,677
MISCELLANEOUS ASSETS	$75,528,114

Field	Value	IRS element (for citing)
Total Book Value Other Assets	$4,098,511,476	TotalBookValueOtherAssetsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (7 entries)

DescDesc	AmtAmt
Federal Income Taxes
OPERATING LEASE LIABILITIES	$417,874,193
RESEARCH ADVANCES	$171,107,436
AMOUNTS DUE THIRD PARTY PAYOR	$70,494,752
SWAP VALUATION LIABILITY	$16,716,692
MISCELLANEOUS LIABILITIES	$16,307,812
PROVISION FOR MEDICAL MALPRACTICE CLAIMS	$2,265,000

Field	Value	IRS element (for citing)
Total Liability	$694,765,885	TotalLiabilityAmt
Other Revenue	$0	OtherRevenueAmt
Revenue Not Reported	$0	RevenueNotReportedAmt
Revenue Subtotal	$0	RevenueSubtotalAmt
Other Revenues Not Included	$0	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	$0	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$0	TotalRevenuePerForm990Amt
Other Expenses Included	$0	OtherExpensesIncludedAmt
Expenses Not Reported	$0	ExpensesNotReportedAmt
Expenses Subtotal	$0	ExpensesSubtotalAmt
Other Expenses Not Included	$0	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$0	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$0	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule D, Part V, Line 4 Intended uses of endowment funds	FormAndLineReferenceDesc
Explanation	DANA-FARBER, INC. (DFI) A RELATED ORGANIZATION OF DANA-FARBER CANCER INSTITUTE, INC. (DFCI) HOLDS THE ENDOWMENTS FOR DFCI. AS DESCRIBED IN THE CONSOLIDATED AUDITED FINANCIAL STATEMENTS, DFCI'S ENDOWMENTS CONSIST SOLELY OF DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR PURPOSES DIRECTLY RELATED TO DFCI'S EXEMPT MISSION AND PURPOSES. AS REQUIRED BY GENERALLY ACCEPTED ACCOUNTING PRINCIPLES, NEW ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS. ALL USES OF DFCI'S ENDOWMENT FUNDS ARE IN FURTHERANCE OF DFCI'S EXEMPT MISSION AND PURPOSES.	ExplanationTxt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)	Program Services	Subcontracted Research	$4,057,000
South Asia	Program Services	Subcontracted Research	$728,000
East Asia and the Pacific	Program Services	RESEARCH AND EDUCATION	$696,000
South America	Program Services	RESEARCH AND EDUCATION	$629,000
North America (Canada & Mexico only)	Program Services	Subcontracted Research	$602,000
East Asia and the Pacific	Program Services	Subcontracted Research	$600,000
Sub-Saharan Africa	Program Services	Subcontracted Research	$237,000
Middle East and North Africa	Program Services	Subcontracted Research	$170,000
Middle East and North Africa	Program Services	RESEARCH AND EDUCATION	$220,000
South America	Program Services	Subcontracted Research	$27,000

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$7,966,000	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$7,966,000	TotalSpentAmt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	Yes (true)	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements	FormAndLineReferenceDesc
Explanation	EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; SOUTH AMERICA-Accrual; SOUTH ASIA-Accrual; SUB-SAHARAN AFRICA-Accrual	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Gross ReceiptsGrossReceiptsAmt	Retained By ContractorRetainedByContractorAmt	Net To OrganizationNetToOrganizationAmt
Moore a Series LLC
4200 PARLIAMENT PLACE THIRD FLOOR	LANHAM	MD	20706	DIRECT MAIL	false	$5,982,709	$3,721,597	$2,261,112
Charles River Interactive Inc
900 Chelmsford St Tower III 10th fl	LOWELL	MA	01851	social media consulting	false		$1,890,571	-$1,890,571
In Voices LLC dba Good to Go
314 ELLIOT ST	MILTON	MA	02186	NEW SPECIAL EVENT AND ONLINE FUNDRAISING STRATEGIES	false		$5,000	-$5,000
Huron Consulting Group Inc
550 W Van Buren Street	CHICAGO	IL	60607	Consulting	false		$7,543	-$7,543

Field	Value	IRS element (for citing)
Total Gross Receipts	$5,982,709	TotalGrossReceiptsAmt
Total Retained By Contractors	$5,624,711	TotalRetainedByContractorsAmt
Total Net To Organization	$357,998	TotalNetToOrganizationAmt
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DC	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	AL	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	BMJF Walk	Event1Nm
Gross Receipts Event1	$11,069,349	GrossReceiptsEvent1Amt
Charitable Contri Event1	$10,880,404	CharitableContriEvent1Amt
Gross Revenue Event1	$188,945	GrossRevenueEvent1Amt
Non Cash Prizes Event1	$0	NonCashPrizesEvent1Amt
Rent Facility Costs Event1	$5,452	RentFacilityCostsEvent1Amt
Food And Beverage Event1	$63,034	FoodAndBeverageEvent1Amt
Entertainment Event1	$23,705	EntertainmentEvent1Amt
Other Direct Expenses Event1	$2,042,325	OtherDirectExpensesEvent1Amt
Event2	RADIO-TELETHON	Event2Nm
Gross Receipts Event2	$5,812,665	GrossReceiptsEvent2Amt
Charitable Contri Event2	$5,812,665	CharitableContriEvent2Amt
Gross Revenue Event2	$0	GrossRevenueEvent2Amt
Non Cash Prizes Event2	$0	NonCashPrizesEvent2Amt
Rent Facility Costs Event2	$10,656	RentFacilityCostsEvent2Amt
Food And Beverage Event2	$3,032	FoodAndBeverageEvent2Amt
Entertainment Event2	$0	EntertainmentEvent2Amt
Other Direct Expenses Event2	$411,740	OtherDirectExpensesEvent2Amt
Other Events Total	5	OtherEventsTotalCnt
Gross Receipts Other Events	$844,641	GrossReceiptsOtherEventsAmt
Charitable Contri Other Events	$461,217	CharitableContriOtherEventsAmt
Gross Revenue Other Events	$383,424	GrossRevenueOtherEventsAmt
Non Cash Prizes Other Events	$725	NonCashPrizesOtherEventsAmt
Rent Fclty Costs Other Events	$58,190	RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events	$30,557	FoodAndBeverageOtherEventsAmt
Entertainment Other Events	$2,752	EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events	$369,922	OthDirectExpnssOtherEventsAmt
Gross Receipts Total	$17,726,655	GrossReceiptsTotalAmt
Charitable Contributions Tot	$17,154,286	CharitableContributionsTotAmt
Gross Revenue Total Events	$572,369	GrossRevenueTotalEventsAmt
Non Cash Prizes Total Events	$725	NonCashPrizesTotalEventsAmt
Rent Fclty Costs Total Events	$74,298	RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events	$96,623	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$26,457	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$2,823,987	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$3,022,090	DirectExpenseSummaryEventsAmt
Net Income Summary	-$2,449,721	NetIncomeSummaryAmt

Schedule H IRS990ScheduleH

Field	Value	IRS element (for citing)
Financial Assistance Policy	Yes (true)	FinancialAssistancePolicyInd
Written Policy	Yes (true)	WrittenPolicyInd
All Hospitals Policy	Yes (X)	AllHospitalsPolicyInd
FPG Reference Free Care	Yes (true)	FPGReferenceFreeCareInd
Percent150	Yes (X)	Percent150Ind
FPG Reference Discounted Care	Yes (true)	FPGReferenceDiscountedCareInd
Percent300	Yes (X)	Percent300Ind
Free Care Medically Indigent	Yes (true)	FreeCareMedicallyIndigentInd
Financial Assistance Budget	Yes (true)	FinancialAssistanceBudgetInd
Expenses Exceed Budget	Yes (true)	ExpensesExceedBudgetInd
Unable To Provide Care	false	UnableToProvideCareInd
Annual Community Bnft Report	Yes (true)	AnnualCommunityBnftReportInd
Report Publically Available	Yes (true)	ReportPublicallyAvailableInd

Financial Assistance At Cost Typ FinancialAssistanceAtCostTyp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$41,227,994	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$26,990,025	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$14,237,969	NetCommunityBenefitExpnsAmt
Total Expense	0.00372	TotalExpensePct

Unreimbursed Medicaid UnreimbursedMedicaidGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$209,061,318	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$134,279,477	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$74,781,841	NetCommunityBenefitExpnsAmt
Total Expense	0.01956	TotalExpensePct

Unreimbursed Costs UnreimbursedCostsGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Total Financial Assistance Typ TotalFinancialAssistanceTyp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$250,289,312	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$161,269,502	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$89,019,810	NetCommunityBenefitExpnsAmt
Total Expense	0.02328	TotalExpensePct

Community Health Services CommunityHealthServicesGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$13,467,742	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$13,467,742	NetCommunityBenefitExpnsAmt
Total Expense	0.00352	TotalExpensePct

Health Professions Education HealthProfessionsEducationGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$8,636,576	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$1,634,961	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$7,001,615	NetCommunityBenefitExpnsAmt
Total Expense	0.00183	TotalExpensePct

Subsidized Health Services SubsidizedHealthServicesGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Research ResearchGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$910,295,134	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$716,661,377	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$193,633,757	NetCommunityBenefitExpnsAmt
Total Expense	0.05064	TotalExpensePct

Cash And In Kind Contributions CashAndInKindContributionsGrp

Field	Value	IRS element (for citing)
Total Community Benefit Expns	$4,260,338	TotalCommunityBenefitExpnsAmt
Net Community Benefit Expns	$4,260,338	NetCommunityBenefitExpnsAmt
Total Expense	0.00111	TotalExpensePct

Total Other Benefits TotalOtherBenefitsGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$936,659,790	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$718,296,338	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$218,363,452	NetCommunityBenefitExpnsAmt
Total Expense	0.05711	TotalExpensePct

Total Community Benefits TotalCommunityBenefitsGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$1,186,949,102	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$879,565,840	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$307,383,262	NetCommunityBenefitExpnsAmt
Total Expense	0.08039	TotalExpensePct

Physical Imprv And Housing PhysicalImprvAndHousingGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Economic Development EconomicDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Community Support CommunitySupportGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Environmental Improvements EnvironmentalImprovementsGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Leadership Development LeadershipDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Coalition Building CoalitionBuildingGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Health Improvement Advocacy HealthImprovementAdvocacyGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Workforce Development WorkforceDevelopmentGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Other Communtity Building Acty OtherCommuntityBuildingActyGrp

Field	Value	IRS element (for citing)
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Total Communtity Building Acty TotalCommuntityBuildingActyGrp

Field	Value	IRS element (for citing)
Activities Or Programs	0	ActivitiesOrProgramsCnt
Persons Served	0	PersonsServedCnt
Total Community Benefit Expns	$0	TotalCommunityBenefitExpnsAmt
Direct Offsetting Revenue	$0	DirectOffsettingRevenueAmt
Net Community Benefit Expns	$0	NetCommunityBenefitExpnsAmt
Total Expense	0.0	TotalExpensePct

Field	Value	IRS element (for citing)
Bad Debt Expense Reported	Yes (true)	BadDebtExpenseReportedInd
Bad Debt Expense	$1,646,424	BadDebtExpenseAmt
Bad Debt Expense Attributable	$16,464	BadDebtExpenseAttributableAmt
Reimbursed By Medicare	$619,296,139	ReimbursedByMedicareAmt
Cost Of Care Reimbursed By Medcr	$705,286,268	CostOfCareReimbursedByMedcrAmt
Medicare Surplus Or Shortfall	-$85,990,129	MedicareSurplusOrShortfallAmt

Costing Methodology Used CostingMethodologyUsedGrp

Field	Value	IRS element (for citing)
Other	Yes (X)	OtherInd

Field	Value	IRS element (for citing)
Written Debt Collection Policy	Yes (true)	WrittenDebtCollectionPolicyInd
Financial Assistance Prvsn	Yes (true)	FinancialAssistancePrvsnInd
Hospital Facilities	1	HospitalFacilitiesCnt

Hospital Facilities HospitalFacilitiesGrp

Field	Value	IRS element (for citing)
Facility	1	FacilityNum

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	DANA-FARBER CANCER INSTITUTE INC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	450 BROOKLINE AVE	AddressLine1Txt
City	BOSTON	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02215	ZIPCd

Field	Value	IRS element (for citing)
Website Address	WWW.DANA-FARBER.ORG	WebsiteAddressTxt
State License	2335	StateLicenseNum
Licensed Hospital	Yes (X)	LicensedHospitalInd
Teaching Hospital	Yes (X)	TeachingHospitalInd
Research Facility	Yes (X)	ResearchFacilityInd

Hospital Fclty Policies Prctc HospitalFcltyPoliciesPrctcGrp

Hospital Facility Name HospitalFacilityName

Field	Value	IRS element (for citing)
Business Name Line1	DANA-FARBER CANCER INSTITUTE INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Facility	1	FacilityNum
First Licensed CY Or PY	false	FirstLicensedCYOrPYInd
Tax Exempt Hospital CY Or PY	false	TaxExemptHospitalCYOrPYInd
CHNA Conducted	Yes (true)	CHNAConductedInd
Community Definition	Yes (X)	CommunityDefinitionInd
Community Demographics	Yes (X)	CommunityDemographicsInd
Existing Resources	Yes (X)	ExistingResourcesInd
How Data Obtained	Yes (X)	HowDataObtainedInd
Community Health Needs	Yes (X)	CommunityHealthNeedsInd
Other Health Issues	Yes (X)	OtherHealthIssuesInd
Community Hlth Needs Id Process	Yes (X)	CommunityHlthNeedsIdProcessInd
Consulting Process	Yes (X)	ConsultingProcessInd
Prior CHNA Impact	Yes (X)	PriorCHNAImpactInd
CHNA Conducted	25	CHNAConductedYr
Take Into Account Others Input	Yes (true)	TakeIntoAccountOthersInputInd
CHNA Conducted With Other Fclts	false	CHNAConductedWithOtherFcltsInd
CHNA Conducted With Non Fclts	false	CHNAConductedWithNonFcltsInd
CHNA Report Widely Available	Yes (true)	CHNAReportWidelyAvailableInd
Rpt Available On Own Website	Yes (X)	RptAvailableOnOwnWebsiteInd
Own Website URL	https://www.dana-farber.org/community-health/community-health-needs-assessment	OwnWebsiteURLTxt
Paper Copy Public Inspection	Yes (X)	PaperCopyPublicInspectionInd
Implementation Strategy Adopt	Yes (true)	ImplementationStrategyAdoptInd
Implementation Strategy Adpt	26	ImplementationStrategyAdptYr
Strategy Posted Website	Yes (true)	StrategyPostedWebsiteInd
Strategy Website URL	HTTPS://WWW.DANA-FARBER.ORG/COMMUNITY-HEALTH/COMMUNITY-HEALTH-NEEDS-ASSESSMENT	StrategyWebsiteURLTxt
Organization Incur Excise Tax	false	OrganizationIncurExciseTaxInd
Elig Criteria Explained	Yes (true)	EligCriteriaExplainedInd
FPG Family Incm Lmt Free Dscnt	Yes (X)	FPGFamilyIncmLmtFreeDscntInd
FPG Family Incm Lmt Free Care	150.0	FPGFamilyIncmLmtFreeCarePct
FPG Family Incm Lmt Dscnt Care	300.0	FPGFamilyIncmLmtDscntCarePct
Medical Indigency Criteria	Yes (X)	MedicalIndigencyCriteriaInd
Explained Basis	Yes (true)	ExplainedBasisInd
App Financial Asst Expln	Yes (true)	AppFinancialAsstExplnInd
Described Info	Yes (X)	DescribedInfoInd
Described Suprt Doc	Yes (X)	DescribedSuprtDocInd
Provided Hospital Contact	Yes (X)	ProvidedHospitalContactInd
Includes Publicity Measures	Yes (true)	IncludesPublicityMeasuresInd
FAP Available On Website	Yes (X)	FAPAvailableOnWebsiteInd
FAP Available On Website URL	https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance	FAPAvailableOnWebsiteURLTxt
FAP App Available On Website	Yes (X)	FAPAppAvailableOnWebsiteInd
FAP App Available On Website URL	https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance	FAPAppAvailableOnWebsiteURLTxt
FAP Summary On Website	Yes (X)	FAPSummaryOnWebsiteInd
FAP Summary On Website URL	https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance	FAPSummaryOnWebsiteURLTxt
FAP Avlbl On Request No Charge	Yes (X)	FAPAvlblOnRequestNoChargeInd
FAP App Avlbl On Request No Chrg	Yes (X)	FAPAppAvlblOnRequestNoChrgInd
FAP Sum Avlbl On Request No Chrg	Yes (X)	FAPSumAvlblOnRequestNoChrgInd
Notified FAP Copy Bill Display	Yes (X)	NotifiedFAPCopyBillDisplayInd
Communtity Notified FAP	Yes (X)	CommuntityNotifiedFAPInd
FAP Translated	Yes (X)	FAPTranslatedInd
FAP Actions On Nonpayment	Yes (true)	FAPActionsOnNonpaymentInd
Permit No Actions	Yes (X)	PermitNoActionsInd
Collection Activities	false	CollectionActivitiesInd
Provided Written Notice	Yes (X)	ProvidedWrittenNoticeInd
Made Effort Orally Notify	Yes (X)	MadeEffortOrallyNotifyInd
Processed FAP Application	Yes (X)	ProcessedFAPApplicationInd
Nondis Emergency Care Policy	Yes (true)	NondisEmergencyCarePolicyInd
Look Back Medicaid Medcr Prvt	Yes (X)	LookBackMedicaidMedcrPrvtInd
Amounts Generally Billed	false	AmountsGenerallyBilledInd
Gross Charges	false	GrossChargesInd

Supplemental Information SupplementalInformationGrp (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule H, Part V, Section B, Line 5 Facility , 1	Facility , 1 - Dana-Farber Cancer Institute ("DFCI"). In 2025, Dana-Farber's Board of Trustees approved the 2025-2028 Cancer-Focused Community Health Needs Assessment (CHNA) and Implementation Plan to ensure that our collective efforts have the maximum possible impact within the Institute's priority neighborhoods. Dana-Farber's Community Benefits Office retained Health Resources in Action (HRiA), a non-profit public health consultancy organization in Boston, to undertake a comprehensive assessment of the health needs within our priority communities, including how those needs are currently being addressed and where there are opportunities to address these needs in the future. The 2025 CHNA and CHIP build on previous efforts and examine the cancer burden across Boston, both overall and among specific population groups. The CHNA and CHIP are grounded in Dana-Farber's commitment to health equity and to addressing social determinants of health (SDoH). As such, this implementation plan aims to be actionable to better support individuals from all backgrounds across the cancer care continuum. The 2025 Dana-Farber CHNA identified multiple geographies and populations who are disproportionately impacted by cancer, access to screenings, and the social and economic factors that give rise to these health disparities. These include the neighborhoods of Dorchester, Mattapan, Roxbury, Mission Hill, Jamaica Plain and East Boston and communities of color, non-English speaking residents, immigrants, low-income residents, people with disabilities, and LGBTQIA+ residents. Dana-Farber is an active member of the Boston Community Health Collaborative (the Collaborative), which is a partnership of Boston health institutions, the Boston Public Health Commission, community health centers, and community organizations working to improve the health and well-being of Boston residents. The Collaborative conducted a large-scale city-wide CHNA in 2025 and many findings from this effort are integrated into this implementation plan particularly in relation to health equity and the social determinants of health. In June 2025, findings from the Boston Community Health Needs Assessment were formally presented to the Dana-Farber Trustees Community Programs Committee and the Dana-Farber Community Benefits External/DoN Advisory Committee. The presentations highlighted citywide trends, inequities, and priority community needs, and helped contextualize and inform Dana-Farber's community health planning and alignment with the upcoming CHNA and CHIP. This alignment ensures that Dana-Farber remains responsive to immediate community needs and supports flexibility and readiness to address issues that might arise in the future. This integrated approach provides a deeper context for cancer-related experiences across Boston's communities. The Collaborative's Needs Assessment and Improvement Plan can be found here: https://www.boston.gov/government/cabinets/boston-public-health-commission/racial-justice-and-health-equity/bostonchna The 2025 Dana-Farber Cancer CHNA uses multiple data sources including data already collected via existing sources (secondary data) and new information gathered for this specific effort (primary data). As noted, this report also incorporates data from the citywide Boston CHNA. The following provides an overview of the methods employed in the 2025 DFCI CHNA and a highlight of the Boston CHNA methods that were incorporated into this report. Please see the 2025-2028 DFCI CHNA Appendix A for a more detailed description of these methods and their limitations and Appendix B for more information on data analyses. Primary data are new data collected specifically for the CHNA. Primary data were collected using 2 different methods: community resident focus groups and a key informant survey. Focus groups for the Dana-Farber Cancer CHNA were carried out in collaboration with community partners in surrounding neighborhoods, including Mission Hill, Dorchester, and East Boston. 91 cancer patients, survivors, and caregivers engaged in 9 focused discussions from February - April 2025. Dana-Farber made introductions and connections for some of these groups. Focus groups were conducted both in-person (90 minutes) and virtually (60-90 minutes) and aimed to delve deeply into experiences with cancer screening, treatment and care coordination, and survivorship. Focus groups were conducted with the following population groups: English-speaking men who specifically are prostate cancer patients/survivors and their caregivers; Latinx residents who speak Spanish (2 groups); Asian residents who speak Cantonese; Asian residents who speak Vietnamese; Residents who speak English (3 groups); Residents who identify as LGBTQIA+. The following community partners assisted with recruiting participants and/or hosting focus groups: Asian Women for Health, DFCI LGBTQIA+ Patient Support Group, Prostate Health Education Network, Roxbury Tenants of Harvard, Union Capital Boston, and VietAID. Focus group notes were coded and analyzed using NVivo, a qualitative analysis software, to identify major categories and sub-themes that emerged across all groups, as well as unique issues specific to particular populations. The frequency and intensity of discussions on a topic were the key drivers used for extracting main themes. Selected de-identified paraphrased quotes are presented to further illustrate points within topic areas. Additionally, 24 providers, organizational leaders, and community residents completed an open-ended key informant survey. The Dana-Farber Key Informant Survey aimed to collect information about key stakeholders' perceptions of community resources and opportunities for improvement. The survey was offered between March - April 2025 to medical providers, navigators, staff from community-based organizations focused on cancer care, and community residents touched by cancer. These individuals were pre-selected by Dana-Farber for their cancer-related expertise. Targeted outreach was conducted primarily through email. The survey tool included 8 open-ended questions and was made available online through Qualtrics in English. In this report, people who completed the survey are referred to as "key informant survey respondents" (whereas those who were part of focus groups are referred to as "participants" for distinction). The final sample includes 24 key informant survey respondents. NVivo was also used to analyze the open-ended survey responses, employing a similar qualitative coding process used for the focus group data noted above. Secondary data are data that has already been collected for another purpose. Examining secondary data helps us to understand trends, provide a baseline, and identify differences by sub-groups. These quantitative findings help guide the methods and populations for primary data collection. As an example, populations for focus groups were prioritized among those groups with the largest cancer burden, lowest screening rates, and challenges with healthcare access. Secondary data for this CHNA were gathered to understand cancer outcomes, risk behaviors, and social determinants of health. Existing data were drawn from national, state, and city sources, including the Boston Behavioral Risk Factor Surveillance Survey (BBRFSS), Massachusetts Department of Public Health, Boston Resident Deaths, U.S. Census American Community Survey (ACS), and Healthy People 2030.
Schedule H, Part V, Section B, Line 5 Facility , 2	Facility , 2 - Dana-Farber Cancer Institute ("DFCI"). Secondary data from the Massachusetts Cancer Registry, Boston Resident Deaths, and Boston Behavioral Risk Factor Surveillance Survey (BRFSS) were analyzed by the Boston Public Health Commission's Center for Public Health Sciences and Innovation. Other data were analyzed by the organizations cited in the data source. Analyses are presented as frequencies (percentages) and rates throughout the report. Data from the surveillance systems, such as the BBRFSS, are presented with 95% confidence intervals (indicating 95% confidence that true value is in the range; noted as error bars in the figures), where possible. Time series analyses examined cancer rates over time across multiple time points. When statistical significance testing was conducted, it is noted in figures or in text. Specifically, when the word "significantly" is used in the text it connotes statistical significance (p<0.05). The following recent presentations and articles from Dana-Farber provided detailed data on specific topics and populations: 2024 Massachusetts Comprehensive Cancer Coalition Statewide Cancer Summit, The Lancet Oncology Disabilities and Cancer Series, Cancer Disparities Experienced by People with Disabilities, Dana-Farber Cancer Institute Intro to Cancer Genetic Counseling, Dana-Farber Cancer Institute Prevent Cancer Dialogue, and Dana-Farber Cancer Institute Inclusion, Diversity, and Equity in Action (IDEA) Lecture Series. Key themes from these related materials were summarized and embedded into relevant sections in the report. The description below is an overview of the Boston CHNA methods, given many findings were included in Dana-Farber's CHNA report. The Boston CHNA Community Survey aimed to collect information about Boston residents' perceptions of community strengths, priority health issues, and access to care and vital resources contributing to health and well-being. The Boston CHNA survey was offered between September 2024 and January 2025 to individuals aged 14 and up living in Boston. The anonymous survey was made available online and in paper format in English and 8 languages in addition to English (Arabic, Cape Verdean Creole, Haitian Creole, Portuguese, Spanish, Simplified Chinese, Somali, and Vietnamese). Intensive community outreach was conducted. Outreach was conducted through various means, including in-person outreach, email distribution, social media and online survey promotion. Building on previous processes, the Boston Community Health Collaborative leveraged a large, existing network of community partners who distributed the survey in online and paper formats. In addition, targeted outreach and paper survey distribution were conducted at 43 community events and locations, including farmer's markets, health fairs, block parties, public libraries, food pantries, and community meetings. Promotional flyers were distributed in all 9 survey languages.The final survey tool included 28 questions. The final sample of the CHNA Community Survey comprises 1,866 respondents who were Boston residents. 8 focus groups were conducted with specific communities of focus from December 2024 through February 2025. A total of 62 community residents participated in focus groups. Focus groups were conducted with the following population groups: South Boston mothers (in Spanish); Chinese older adults (in Cantonese); Residents in active substance use recovery; New immigrants and/or English language learners; Residents who live in Boston Housing Authority housing; Somali parents of children with special healthcare needs (in Somali); Fathers and men of color; Refugee youth. Additionally, 5 sector-based focus groups were conducted with 28 organizational partners and direct service providers. The sectors and topic areas for these groups were: Climate Justice, Housing, Community Health Workers, Mental/Behavioral Health, and Economic Mobility. These discussions aimed to focus in particular on community needs, assets, and promising practices or recommendations for action.Additionally, a total of eleven key informant interviews were completed with 13 individuals between January and March 2025.
Schedule H, Part V, Section B, Line 11 Facility , 1	Facility , 1 - Dana-Farber Cancer Institute ("DFCI"). The goals and strategies outlined in the 2025-2028 Implementation Plan are specifically designed to recognize the milestones we have reached thus far, address new findings based on emerging public health research, and continue the work of achieving the goals we have set to help meet the health needs of our surrounding communities. As part of our approach to implementing the identified strategies, we will continue our existing community-based programming, which includes assessing the most effective evidence-based interventions, collaborating with community partners to implement community health improvement efforts, and conducting ongoing evaluation of program effectiveness. Our expertise as a comprehensive cancer center leads us to focus largely on reducing cancer incidence and mortality among medically underserved populations through our clinical community screening and outreach programs, which include mobile mammography and breast health education, skin cancer education and screening, HPV education and vaccination, tobacco cessation and increasing awareness about survivorship in communities of color. The 2025-2028 Implementation Plan focuses on the following areas: 1) Cancer Screening (Routine, Underutilized, and Emerging): Increasing access to and uptake of cancer screenings, particularly among populations experiencing lower screening rates; 2) Access to Care: Improving awareness, navigation, and access to timely, high-quality care across the cancer continuum; 3) Cancer Care Coordination and Treatment: Enhancing patient navigation, care coordination, and support throughout diagnosis, treatment, and survivorship; and 4) Social Determinants of Health: Addressing upstream factors - including food access, economic mobility, healthy living, and housing - that influence cancer risk and outcomes. Dana-Farber is a comprehensive cancer care specialty hospital committed to supporting communities across the cancer continuum, with a particular focus on marginalized populations. While the CHNA revealed a broad range of needs, this implementation plan focuses on areas where Dana-Farber's expertise, clinical capacity, and resources can have the greatest impact. Dana-Farber's leadership is committed to sustaining the resources required to advance these Community Health priorities and to strengthening efforts that reduce cancer disparities and improve health outcomes in the communities we serve. Dana-Farber remains engaged in broader public health efforts. As an active leader in the Collaborative, Dana-Farber collaborates with partners to address root causes of health inequities and to advance shared goals that extend beyond cancer care. While needs such as childcare or substance use may fall outside Dana-Farber's primary cancer-focused scope, we recognize their connection to the cancer care continuum, and they will be addressed at the individual patient level. Considerable progress has been made in advancing the goals set in our 2022-2025 CHNA Implementation Plan. Community Health efforts increased preventive screening and improved treatment access, deepened culturally and linguistically responsive outreach and education, and advanced policy and systems changes that addressed root causes of health inequities. The highlights summarized below reflect key accomplishments and demonstrate the collective impact of our work. * Delivered 6,784 mammograms (4,513 via the mobile van; 2,271 at Whittier Street Health Center); and worked to increase the follow-up rate for those with abnormal screening results. * Conducted skin cancer screening and provided education for 2,526 people at 49 events; 416 abnormal findings referrals and 175 biopsy referrals made; digitized an updated interactive sun safety curriculum. * Provided 208 tobacco cessation counseling sessions to seventy-five patients; 84% reduced daily cigarette use and 41% quit; supplied nicotine replacement therapy and gift cards for healthy snacks. * Engaged 1,700+ residents via virtual cancer prevention sessions with Union Capital. * Launched AssessYourRisk (AYR), a free online tool in English and Spanish, to assess risk of breast and ovarian cancers and offer resources to reduce these risks; over 14,000 AYR completions in 16 months. * Hired four bilingual Community Outreach Specialists; presented in English, Spanish, Cantonese, Mandarin, and Haitian Creole to groups including low-income residents, immigrants and men. * Expanded outreach via Chinese and Spanish media (e.g. WeChat, El Mundo). * Distributed a 7-language HPV Dental Toolkit and created LGBTQIA+- tailored education materials with Team Maureen while leading the MA HPV Coalition. * Funded and evaluated four multi-year Greater Boston non-profit organizations through DoN grantmaking focused on environmental justice, food insecurity, and child homelessness; achieved legislative wins, strengthened resident power-building and advocacy, and shared evaluation learnings at national and local meetings. * Cancer Care Access Program provided streamlined diagnostic resolution and treatment for underserved medically complex patients with suspected malignancies at three Boston FQHCs. * Expanded patient navigation to Gynecologic, Lymphoma, Myeloma, and Genitourinary cancer centers. * Strengthened Dana-Farber patient demographic data and began routine patient SOGI collection. * Earned Joint Commission Health Equity Certification. * Secured state approvals for a new 300-bed inpatient cancer hospital.

Field	Value	IRS element (for citing)
Facility	9	FacilityNum

Oth Hlth Care Fclts Not Hospital OthHlthCareFcltsNotHospitalGrp

Oth Hlth Care Fclts OthHlthCareFcltsGrp (10 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	FacilityFacilityTxt	Address Line2USAddress/AddressLine2Txt
DFBWCC AT SOUTH SHORE HOSPITAL
101 COLUMBIAN STREET	SOUTH WEYMOUTH	MA	02190	SATELLITE
DFBWCC AT MILFORD REGIONAL MEDICAL CENTER
20 PROSPECT STREET	MILFORD	MA	01757	SATELLITE
DFCI - CHESTNUT HILL
300 BOYLSTON STREET	NEWTON	MA	02459	SATELLITE
DFCI - MERRIMACK VALLEY
5 BRANCH STREET	METHUEN	MA	01844	SATELLITE
DFNH ONCOLOGY-HEMATOLOGY
ELLIOTT MED CENTER 40 BUTTRICK RD S	LONDONDERRY	NH	03053	SATELLITE	TE B
DFCI-BRIGHTON
CUSHING PAVILION 736 CAMBRIDGE STRE	BRIGHTON	MA	02135	SATELLITE	ET
DFCI - LIBBEY PARK
51 PERFORMANCE DRIVE	WEYMOUTH	MA	02189	SATELLITE
DFCI - MOBILE MAMMOGRAPHY SERVICE
450 BROOKLINE AVENUE	BOSTON	MA	02215	SATELLITE
DFCI - WHITTIER STREET HEALTH CENTER
1290 TREMONT STREET	ROXBURY	MA	02120	SATELLITE
DANA-FARBER CANCER INSTITUTE - FOXBOROUGH
22 PATRIOT PLACE	FOXBOROUGH	MA	02035	SATELLITE

Supplemental Information Detail SupplementalInformationDetail (20 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule H, Part I, Line 3c Patient education of eligibility for assistance	IN ADDITION TO DETERMINING ELIGIBILITY FOR DISCOUNTED CARE BASED ON FAMILY INCOME, DFCI OFFERS ASSISTANCE TO PATIENTS WHO HAVE EXCESSIVE MEDICAL BILLS (EXCEEDING 30-40% OF FAMILY INCOME).
Schedule H, Part I, Line 6a Community information	THE COMMUNITY BENEFIT REPORT WAS COMPLETED BY DFCI AND IS ANNUALLY PROVIDED TO THE MASSACHUSETTS ATTORNEY GENERAL'S OFFICE, WHERE IT IS THEN MADE PUBLIC ON ITS WEBSITE.
Schedule H, Part I, Line 7 State filing of community benefit report	DFCI'S STATE COST REPORT WAS USED TO DEVELOP THE INSTITUTE'S COST TO CHARGE RATIO THAT WAS APPLIED TO CHARITY CARE CHARGES TO DETERMINE THE COST OF FINANCIAL ASSISTANCE (LINE 7A). LINE 7B REFLECTS THE SPECIFIC LOSS INCURRED FOR THE INSTITUTE'S MEDICAID ACTIVITY. THE INSTITUTE IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTE TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER. THE AMOUNT REPORTED AS HEALTH TRAINING REPRESENT COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. DEPARTMENT LEADERS SUBMIT EXPENDITURES TO COMMUNITY BENEFITS ALONG WITH A DESCRIPTION OF THE SERVICES PROVIDED TO MEDICALLY UNDERSERVED POPULATIONS. LINE 7F EXPENDITURES ARE REVIEWED BY LEADERSHIP AND IN PARTNERSHIP WITH DFCI'S OFFICE OF FINANCE, THE EXPENDITURES ARE APPROVED. THE AMOUNTS ARE CAPTURED IN THREE BUCKETS - CB EXPENDITURES (ALL PROGRAMS); LEVERAGED FUNDS (THOSE FUNDS SUPPORTED IN FULL OR PART THROUGH GRANTS/DONATIONS) AND COMMUNITY SPONSORSHIPS.
Schedule H, Part V SECTION A & D	DFCI'S MAIN CAMPUS IS LOCATED 450 BROOKLINE AVE., BOSTON, MA, 02115. DFCI'S SATELLITE LOCATIONS (BELOW) EACH OPERATE UNDER THE SAME HOSPITAL LICENSE. DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT MILFORD HOSPITAL, 20 PROSPECT STREET, MILFORD, MA 01757 DANA-FARBER/BRIGHAM AND WOMEN'S CANCER CENTER AT SOUTH SHORE HOSPITAL, 101 COLUMBIAN STREET, SOUTH WEYMOUTH, MA 02190 DANA-FARBER - BRIGHTON, 736 CAMBRIDGE STREET, CUSHING PAVILION, 5TH FLOOR, BRIGHTON, MA 02135 DANA-FARBER CANCER INSTITUTE - CHESTNUT HILL, 300 BOYLSTON STREET, NEWTON, MA 02459 DANA-FARBER CANCER INSTITUTE - MERRIMACK VALLEY, 5 BRANCH STREET, METHUEN, MA 01844 DANA-FARBER CANCER INSTITUTE - FOXBOROUGH, 22 PATRIOT PLACE, FOXBOROUGH, MA, 02035 DANA-FARBER CANCER INSTITUTE - LIBBEY PARK, 51 PERFORMANCE DRIVE, WEYMOUTH, MA 02189 DANA-FARBER CANCER INSTITUTE - MOBILE MAMMOGRAPHY SERVICE, 450 BROOKLINE AVENUE, BOSTON, MA 02215 DANA-FARBER CANCER INSTITUTE - WHITTIER STREET HEALTH CENTER, 1290 TREMONT STREET, ROXBURY, MA 02120 DANA-FARBER/NEW HAMPSHIRE ONCOLOGY HEMATOLOGY ALSO OPERATES A CLINICAL LOCATION AT 40 BUTTRICK ROAD, SUITE B, LONDONDERRY, NH 03053.
Schedule H, Part III Section A, Lines 2 and 3 - Bad Debt Expense	IN CALCULATING BAD DEBT EXPENSE, DFCI USES A COMBINATION OF ACTUAL BAD DEBT WRITE OFFS AND HISTORICAL BAD DEBT FACTORS IN DETERMINING WHICH CURRENT ACCOUNTS RECEIVABLE ARE NOT LIKELY TO BE COLLECTED. ADDITIONALLY, DFCI DETERMINES THE AMOUNT OF BAD DEBT ATTRIBUTABLE TO INDIVIDUALS WHO ARE ELIGIBLE FOR FINANCIAL ASSISTANCE BASED ON A HISTORICAL ESTIMATE OF THE PERCENTAGE OF PATIENTS THAT HAVE QUALIFIED FOR FINANCIAL ASSISTANCE, WHICH IS APPLIED AGAINST TOTAL BAD DEBT.
Schedule H, Part V, Section B, Line 20d Billing and collections	DANA-FARBER DOES NOT ENGAGE IN PRESUMPTIVE ELIGIBILITY FOR ITS PATIENT FINANCIAL ASSISTANCE POLICY (FAP). THROUGH ITS PARTICIPATION IN THE MASSACHUSETTS HEALTH SAFETY NET, THE STATE SPONSORED UNCOMPENSATED PROGRAM, DANA-FARBER FIRST RELIES ON DEMONSTRATION OF INELIGIBILITY FOR MASSHEALTH PROGRAMS, SUCH AS HEALTH SAFETY NET, OR SIMILAR OUT OF STATE MEDICAID PROGRAMS, FROM PATIENTS APPLYING FOR ASSISTANCE. UPON DETERMINATION BY THE STATE AGENCY, DANA-FARBER WILL CONSIDER EACH CASE INDIVIDUALLY AND RELIES ON THE COMPLETION OF THE PATIENT FINANCIAL ASSISTANCE APPLICATION ("PFA APPLICATION") AND PROVISION OF NECESSARY SUPPORTING DOCUMENTATION.
Schedule H, Part V, Section B, Line 22 Charges to FAP eligible individuals	DEPENDING ON A PATIENT'S FINANCIAL SITUATION, FAP-ELIGIBLE PATIENTS WERE CHARGED AMOUNTS RANGING FROM 0% OF BILLED CHARGES UP TO THE APPLICABLE AGB PERCENTAGE OF BILLED CHARGES, WHICH WAS NOT MORE THAN THE AGB. IN FY25, DFCI DETERMINED AGB ON AN ANNUAL BASIS USING THE "LOOK-BACK METHOD," DESCRIBED UNDER TREASURY REGULATION SECTION 1.501(R)-5(B)(1). SPECIFICALLY, DFCI'S ANNUAL AGB PERCENTAGE WAS EQUAL TO SUM OF ALL GROSS CHARGES DURING THE PRIOR FISCAL YEAR DIVIDED BY CLAIMS PAID IN CONNECTION WITH THOSE CHARGES. FOR PURPOSES OF THE AGB CALCULATION, CLAIMS PAID INCLUDED CLAIMS FOR EMERGENCY AND MEDICALLY NECESSARY CARE PAID BY BOTH MEDICARE FEE-FOR-SERVICE AND ALL PRIVATE HEALTH INSURERS AS PRIMARY PAYERS, TOGETHER WITH ANY ASSOCIATED PORTIONS OF THESE CLAIMS PAID BY MEDICARE BENEFICIARIES OR INSURED INDIVIDUALS IN THE FORM OF CO-PAYMENTS, CO-INSURANCE OR DEDUCTIBLES.
Schedule H, Part I, Line 6a Community benefit report prepared by related organization	DANA-FARBER CANCER INSTITUTE ("DFCI")
Schedule H, Part I, Line 7 Bad Debt Expense excluded from financial assistance calculation	1646424
Schedule H, Part III, Line 4 Bad debt expense - financial statement footnote	CONSISTENT WITH THE INSTITUTE'S MISSION, CARE IS PROVIDED TO PATIENTS REGARDLESS OF THEIR ABILITY TO PAY. THE INSTITUTE HAS DETERMINED IT HAS PROVIDED IMPLICIT PRICE CONCESSIONS TO UNINSURED PATIENTS AND PATIENTS WITH OTHER UNINSURED BALANCES (E.G. COPAYS AND DEDUCTIBLES). THE IMPLICIT PRICE CONCESSIONS INCLUDED IN ESTIMATING THE TRANSACTION PRICE REPRESENT THE DIFFERENCE BETWEEN AMOUNTS BILLED TO PATIENTS AND THE AMOUNTS THE INSTITUTE EXPECTS TO COLLECT BASED ON ITS COLLECTION HISTORY WITH THOSE PATIENTS. PATIENTS WHO MEET THE INSTITUTE'S CRITERIA FOR CHARITY CARE ARE PROVIDED CARE WITHOUT CHARGE OR AT AMOUNTS LESS THAN ESTABLISHED RATES. THE INSTIUTE HAS DETERMINED THAT IT HAS PROVIDED SUFFICIENT IMPLICIT PRICE CONCESSIONS FOR THESE ACCOUNTS. PRICE CONCESSIONS, INCLUDING CHARITY CARE, ARE NOT REPORTED AS REVENUE.
Schedule H, Part III, Line 8 Community benefit & methodology for determining medicare costs	THE MEDICARE COST ON LINE 6 COMES FROM THE MEDICARE COST REPORT AND IS BASED ON MEDICARE'S COST FINDING PRINCIPLES AND METHODOLOGIES. WE STRONGLY BELIEVE THAT THE ENTIRE AMOUNT OF THE SHORTFALL OF $85,990,129 SHOULD BE TREATED AS A COMMUNITY BENEFIT AS THIS REPRESENTS THE INSTITUTE'S COMMITMENT TO THE ELDERLY AND DISABLED COMMUNITY BY PROVIDING SERVICES THAT ARE NOT REIMBURSED.
Schedule H, Part III, Line 9b Collection practices for patients eligible for financial assistance	WITHIN DFCI'S CREDIT AND COLLECTIONS POLICY THERE ARE PROVISIONS THAT DESCRIBE COLLECTION PRACTICES TO BE FOLLOWED FOR PATIENTS WHO ARE KNOWN TO QUALIFY FOR CHARITY CARE OR FINANCIAL ASSISTANCE IN ACCORDANCE WITH FEDERAL AND MASSACHUSETTS LAW.
Schedule H, Part V, Section B, Line 16a FAP website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16a URL: https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance;
Schedule H, Part V, Section B, Line 16b FAP Application website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16b URL: https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance;
Schedule H, Part V, Section B, Line 16c FAP plain language summary website	- DANA-FARBER CANCER INSTITUTE, INC.: Line 16c URL: https://www.dana-farber.org/patient-family/support-services/patient-financial-assistance;
Schedule H, Part VI, Line 2 Needs assessment	DANA-FARBER CANCER INSTITUTE CONTINUOUSLY ASSESSES THE COMMUNITY NEEDS THROUGH OUR PARTICIPATION IN COMMUNITY COALITIONS, TASK FORCES, WORKING GROUPS AND DIRECT COMMUNICATION WITH THE COMMUNITY RESIDENTS THAT SERVE ON OUR EXTERNAL ADVISORY COMMITTEE AND ON OUR PATIENT AND FAMILY ADVISORY BOARD. A FULL DESCRIPTION OF OUR COMMUNITY ENGAGEMENT PROCESS CAN BE FOUND ON OUR WEBSITE BOTH IN THE COMMUNITY HEALTH NEEDS ASSESSMENT REPORT AND IN THE COMMUNITY HEALTH IMPLEMENTATION PLAN.
Schedule H, Part VI, Line 3 Patient education of eligibility for assistance	DFCI IS COMMITTED TO OFFERING FINANCIAL ASSISTANCE TO ELIGIBLE PATIENTS WHO DO NOT HAVE THE ABILITY TO PAY FOR THEIR MEDICAL SERVICES IN WHOLE OR IN PART. IN ORDER TO ACCOMPLISH THIS CHARITABLE GOAL, DFCI WIDELY PUBLICIZES ITS PATIENT FINANCIAL ASSISTANCE (PFA) POLICY WITHIN ITS FACILITIES, IN DIRECT COMMUNICATIONS WITH PATIENTS AND IN THE COMMUNITIES THAT IT SERVES, PARTICULARLY IN THE COMMUNITIES WITH THE GREATEST UNMET HEALTH NEEDS. THE PFA POLICY, A PLAIN LANGUAGE PFA SUMMARY AND THE PFA APPLICATION ARE POSTED ON DFCI'S WEBSITE IN ENGLISH AND SPANISH. IN ADDITION, INFORMATION ABOUT THE PFA IS PROVIDED TO ALL PATIENTS AT REGISTRATION AND/OR ADMISSION, AND IS AVAILABLE UPON REQUEST, WITHOUT CHARGE, THROUGH A DFCI FINANCIAL COUNSELOR, CUSTOMER SERVICE REPRESENTATIVE, OR BY MAIL. FOLLOWING CARE, ALL BILLING STATEMENTS SENT TO A PATIENT INDICATE HOW THE PATIENT CAN OBTAIN INFORMATION ABOUT THE PFA POLICY. IN COLLABORATION WITH DFCI'S COMMUNITY PARTNERS, INFORMATION ABOUT THE FAP IS SHARED WITH RESIDENTS OF DFCI'S PRIORITY NEIGHBORHOODS. EFFORTS TO NOTIFY COMMUNITY MEMBERS MOST LIKELY TO REQUIRE ASSISTANCE INCLUDE DISTRIBUTING PLAIN LANGUAGE SUMMARIES OF THIS POLICY TO LOCAL COMMUNITY HEALTH CENTERS AND OTHER NON-PROFIT ORGANIZATIONS.
Schedule H, Part VI, Line 4 Community information	DANA-FARBER SERVES THE COMMUNITY OF EASTERN MASSACHUSETTS, INCLUDING THE COMMUNITIES SURROUNDING ITS PRIMARY LOCATION IN BOSTON AND ITS SATELLITE LOCATIONS IN MILFORD, MASSACHUSETTS, WEYMOUTH, MASSACHUSETTS, BRIGHTON, MASSACHUSETTS, NEWTON, MASSACHUSETTS, METHUEN, MASSACHUSETTS, FOXBOROUGH, MASSACHUSETTS AND LONDONDERRY, NEW HAMPSHIRE. DANA-FARBER'S COMMUNITY INCLUDES ADULTS AND CHILDREN WITH CANCER OR AT RISK OF DEVELOPING CANCER, AND THEIR FAMILIES. Dana-Farber focuses its community outreach efforts on its priority Boston neighborhoods of Dorchester, East Boston, Jamaica Plain, Mattapan, Mission Hill, and Roxbury. The median incomes of Dana-Farber's priority communities are generally much lower than Boston overall, with Roxbury at a median income of $47,921, Dorchester at $58,681, and Mattapan at $67,206. Residents in Dana-Farber's priority neighborhoods appear to experience higher rates of poverty than Boston overall.
Schedule H, Part VI, Line 5 Promotion of community health	Dana-Farber's 2025-2028 Community Health Needs Assessment and Implementation Plan provide a robust description of our comprehensive cancer control programs and services. The report also provides a summary of accomplishments from our last needs assessment and sets forth our commitment to addressing the new opportunities to reduce the cancer burden in medically underserved communities in Boston. The reports can be found using the following links: COMMUNITY HEALTH NEEDS ASSESSMENT - https://www.dana-farber.org/community-health/community-health-needs-assessment IMPLEMENTATION PLAN -https://www.dana-farber.org/community-health/community-health-needs-assessment
Schedule H, Part VI, Line 7 State filing of community benefit report	MA

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (true)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (34 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt	Address Line2USAddress/AddressLine2Txt
CITY OF BOSTON
City Hall Plaza	Boston	MA	02114	046001380	115	$1,692,833	Community Support
HARVARD UNIVERSITY
60 Oxford St	Cambridge	MA	02138	042103580	501(c)(3)	$1,493,414	Cancer Research and Development
ALTERNATIVES FOR COMMUNITY
2181 WASHINGTON STREET SUITE 301	ROXBURY	MA	02119	043228509	501(c)(3)	$199,998	Community Support
FamilyAid Boston
3815 Washington St	Boston	MA	02130	042105756	501(c)(3)	$184,236	Community Support
BOSTON ATHLETIC ASSOCIATION
40 TRINITY PLACE 4TH FLOOR	BOSTON	MA	02116	046111707	501(c)(3)	$160,000	Community Support
Project Bread
145 Border Street	East Boston	MA	02128	042931195	501(c)(3)	$100,000	Community Support
GREENROOTS INC
90 EVERETT AVE 3RD FLOOR SUITE 10	CHELSEA	MA	021502317	812718273	501(c)(3)	$100,000	Community Support
FRIENDS OF DANA FARBER
450 Brookline Ave	Boston	MA	02215	371613621	501(c)(3)	$50,000	Cancer Research and Development
Conference Of Boston Teaching Hospitals
11 Beacon ST Suite 625	BOSTON	MA	01208	263583138	501(c)(6)	$50,000	Community Support
HEALTH EQUITY COMPACT INC
40 COURT ST FL 10	BOSTON	MA	021082212	990943875	501(c)(3)	$50,000	Community Support
AMERICAN CANCER SOCIETY
250 Williams St	Atlanta	GA	30303	131788491	501(c)(3)	$30,000	Cancer Research and Development
BLOOD CANCER UNITED INC
PO BOX 22470	NEW YORK	NY	10087	135644916	501(c)(3)	$25,000	Cancer Research and Development
ALLSTON BRIGHTON COMMUNITY DEVELOPMENT
18R SHEPARD STREET SUITE 100	BRIGHTON	MA	02135	042716278	501(c)(3)	$21,000	Community Support
WHITTIER STREET HEALTH CENTER
1125 Tremont Street	Roxbury	MA	02120	042619517	501(c)(3)	$20,000	Community Support
JOE ANDRUZZI FOUNDATION INC
49 PLAIN ST	NORTH ATTLEBORO	MA	02760	252017043	501(c)(3)	$20,000	Cancer Research and Development
THE DINNER GROUP INC
3096 WASHINGTON STREET	CANTON	MA	02021	842261255	509(a)(2)	$20,000	Community Support
THE BREAST CANCER RESEARCH FOUNDATION
60 EAST 56TH STREET 8TH FLOOR	NEW YORK	NY	10022	133727250	501(c)(3)	$15,000	Cancer Research and Development
PANCREATIC CANCER ACTION NETWORK
1500 ROSECRANS AVENUE SUITE 3200	EL SEGUNDO	CA	90245	330841281	501(c)(3)	$15,000	Cancer Research and Development
HEALTH CARE FOR ALL
30 WINTER STREET	BOSTON	MA	02108	043071598	501(c)(3)	$12,000	Community Support
COMMUNITY SERVINGS
179 Armory Street	Jamaica Plain	MA	02130	223154028	501(c)(3)	$10,000	Community Support
MASSACHUSETTS LEAGUE OF COMMUNITY
40 Court Street 10Th Floor	Boston	MA	02108	042507409	501(c)(3)	$10,000	Community Support
SUSAN G KOMEN BREAST CANCER FOUNDATION
5005 Lbj Suite 370	Dallas	TX	75380	751835298	501(c)(3)	$10,000	Cancer Research and Development
UNION CAPITAL BOSTON INC
1542 COLUMBUS AVENUE	ROXBURY	MA	02119	471136081	501(c)(3)	$10,000	Community Support
CRISTO REY BOSTON HIGH SCHOOL INC
100 SAVIN HILL AVENUE	BOSTON	MA	02125	562438544	501(c)(3)	$10,000	Community Support
UNITED NEGRO COLLEGE FUND INC
1805 7TH STREET NW	WASHINGTON	DC	20001	131624241	501(c)(3)	$10,000	Community Support
AMERICAN INDIAN CANCER FOUNDATION
34 13TH AVE NE SUITE 112	MINNEAPOLIS	MN	55413	270300026	501(c)(3)	$10,000	Cancer Research and Development
JUNIOR ACHIEVEMENT OF GREATER BOSTON IN
80 CITY SQ	BOSTON	MA	021293742	042127020	501(c)(3)	$10,000	Community Support
NEW ENGLAND COUNCIL INC
98 NORTH WASHINGTON STREET	BOSTON	MA	02114	041661090	501(c)(6)	$10,000	Community Support	SUITE 303
RESEARCHAMERICA
241 18TH ST S SUITE 501	ARLINGTON	VA	22202	521609875	501(c)(3)	$10,000	Cancer Research and Development
YOUTH ENRICHMENT SERVICES
412 MASSACHUSETTS AVENUE	BOSTON	MA	02118	042509466	501(c)(3)	$10,000	Community Support
BOYS & GIRLS CLUB OF BOSTON
200 High Street Suite 3B	BOSTON	MA	02110	042103922	501(c)(3)	$7,500	Community Support
NATIONAL MARROW DONOR PROGRAM
500 N 5th St	MINNEAPOLIS	MN	55401	840865803	501(c)(3)	$7,500	Cancer Research and Development
NEW ENGLAND EMPLOYEE BENEFITS COUNCIL
561 VIRGINIA RD SUITE 217	CONCORD	MA	01742	042725284	501(c)(3)	$7,000	Community Support
SOCIEDAD LATINA INC
1530 TREMONT STREET	ROXBURY	MA	02120	042678255	501(c)(3)	$5,500	Community Support

Field	Value	IRS element (for citing)
Total501c3 Org	32	Total501c3OrgCnt
Total Other Org	2	TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (2 entries)

Grant TypeGrantTypeTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Non Cash AssistanceNonCashAssistanceDesc	Non Cash AssistanceNonCashAssistanceAmt	Valuation Method UsedValuationMethodUsedDesc
Patient Assistance	810	$913,492	Miscellaneous
Patient Assistance	3547		Asst Living & Travel	$2,765,629	FMV

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	Schedule I, Part I, Line 2 Procedures for monitoring use of grant funds	FormAndLineReferenceDesc
Explanation	PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS ALL GRANTS AND DONATIONS TO DOMESTIC ORGANIZATIONS WERE GIVEN TO 501(C)(3) ORGANIZATIONS TO FULFILL THEIR MISSIONS, OR GOVERNMENT ENTITIES. ALL GRANT FUNDS TO INDIVIDUALS WERE PROVIDED BASED ON EITHER (AND ONLY) 1) MEANS-TESTED FINANCIAL NEED, OR 2) CLINICALLY DETERMINED IMPROVEMENT TO QUALITY-OF-LIFE.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Idemnification Gross Up Pmts	Yes (X)	IdemnificationGrossUpPmtsInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	false	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (21 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Benjamin Ebert MD PhD
TRUSTEE, PRESIDENT, & CEO (AS OF 10/1/24)	$427,658	$0	$0	$0	$40,433	$0	$48,495	$0	$14,929	$0	$531,515	$0	$0	$0
John O Chesley ESQ
Former Officer	$416,000	$0	$74	$0	$1,458	$0	$0	$0	$172	$0	$417,704	$0	$0	$0
Bruce Johnson MD
Former	$67,846	$0	$116,794	$0	$106,027	$0	$10,772	$0	$31,314	$0	$332,753	$0	$0	$0
William Hahn MD PHD
COO & EVP	$992,361	$0	$372,372	$0	$88,539	$0	$48,495	$0	$3,598	$0	$1,505,365	$0	$0	$0
Michael L Reney
CFO & Assistant Treasurer	$832,796	$0	$316,316	$0	$68,640	$0	$48,495	$0	$3,676	$0	$1,269,923	$0	$0	$0
Jennifer Willcox ESQ
Asst Secretary & General Counsel	$623,292	$0	$165,466	$0	$83,551	$0	$48,495	$0	$37,234	$0	$958,038	$0	$0	$0
Sylvia A Bartel RPh MHP
SR. VP of Pharmacy & CPO	$333,531	$0	$32,203	$0	$8,423	$0	$48,495	$0	$40,140	$0	$462,792	$0	$0	$0
Craig A Bunnell MD MPH MBA
Chief Medical Officer	$781,580	$0	$215,329	$0	$69,774	$0	$48,496	$0	$41,367	$0	$1,156,546	$0	$0	$0
Melany Duval
SVP & Chief Philanthropy Officer	$830,831	$0	$257,160	$0	$66,119	$0	$48,404	$0	$22,696	$0	$1,225,210	$0	$0	$0
Wendy Gettleman
VP of Facilities Management & Real Estate	$363,183	$0	$34,685	$0	$2,642	$0	$47,976	$0	$43,957	$0	$492,443	$0	$0	$0
Kevin Haigis PHD
Chief Scientific Officer	$556,399	$0	$104,499	$0	$30,908	$0	$48,495	$0	$3,555	$0	$743,856	$0	$0	$0
Naomi Lenane
SVP INFORMATION SERVICES CIO	$142,430	$0	$26,333	$0	$575	$0	$15,563	$0	$13,749	$0	$198,650	$0	$0	$0
Patrick McCormick
SVP HOSPITAL TRANSFORMATION	$195,659	$0	$125,000	$0	$73,510	$0	$0	$0	$10,879	$0	$405,048	$0	$0	$0
Jeffrey Meyerhardt MD MPH
Chief Clinical Research Officer	$588,372	$0	$128,236	$0	$36,179	$0	$48,495	$0	$43,564	$0	$844,846	$0	$0	$0
Maria Megdal
SVP Chief Administrative Officer	$436,433	$0	$142,317	$0	$70,880	$0	$48,495	$0	$58,912	$0	$757,037	$0	$0	$0
Barrett J Rollins MD PHD
Sr. Advisor to President & CEO	$530,411	$0	$0	$0	$34,935	$0	$48,495	$0	$11,867	$0	$625,708	$0	$0	$0
Scott Armstrong MD PHD
Chair of Pediatric Oncology	$653,064	$0	$123,907	$0	$66,355	$0	$48,495	$0	$36,047	$0	$927,868	$0	$0	$0
Michael Constantine MD
Milford Med Dir-Hematology/Oncology	$722,581	$0	$52,849	$0	$56,220	$0	$48,495	$0	$44,624	$0	$924,769	$0	$0	$0
George D Demetri MD
PROFESSOR	$624,541	$0	$107,762	$0	$49,161	$0	$48,495	$0	$23,521	$0	$853,480	$0	$0	$0
Laurie H Glimcher MD
President & CEO Emerita	$1,461,748	$0	$695,680	$0	$155,591	$0	$347,058	$0	$19,573	$0	$2,679,650	$0	$0	$0
Robert Soiffer MD
Chief Clinical Program Officer	$655,296	$0	$160,997	$0	$65,893	$0	$48,495	$0	$23,239	$0	$953,920	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule J, Part I, Line 1a Tax indemnification and gross-up payments	FOR THE FOLLOWING, BENEFITS REPORTED IN PART VII INCLUDES GROSS-UP PAYMENTS FOR AN EMPLOYEE RECOGNITION PROGRAM AWARD: 5 KEY EMPLOYEES 1 OFFICER 1 FORMER OFFICER
Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan	THE FOLLOWING INDIVIDUALS PARTICIPATE IN 457(F) PLANS ESTABLISHED BY DFCI; TAXABLE AMOUNTS ARE INCLUDED IN REPORTABLE COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III): OTHER REPORTABLE COMPENSATION INCLUDES LOAN FORGIVENESS AND CURRENT YEAR VESTING AMOUNTS IN DANA-FARBER INSTITUTE'S SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. Laurie Glimcher, MD - $140,759 Bruce Johnson, MD - $103,372 William Hahn, MD, Ph.D - $81,145 Jennifer Willcox, ESQ - $77,848 Maria Megdal - $67,043 Melany Duval - $61,217 Michael Reney - $61,116 Craig A. Bunnell, MD - $56,650 Michael Constantine, MD - $48,696 Scott Armstrong, MD - $39,616 Robert Soiffer, MD - $39,344 George D. Demetri, MD - $35,537 Jeffrey Meyerhardt, MD, Ph.D - $31,795 Kevin Haigis, Ph.D - $26,656 Barrett J. Rollins, MD, Ph.D - $23,349 Benjamin Ebert, MD, Ph.D - $11,197 Sylvia Bartel, RPh, MHP - $245
Schedule J, Part I, Line 7 Non-fixed payments	DURING THE YEAR, THE CEO, COO, CFO, GENERAL COUNSEL, CERTAIN KEY EMPLOYEES AND HIGHEST COMPENSATED EMPLOYEES WERE ELIGIBLE TO RECEIVE AN INCENTIVE PAYMENT, A PORTION OF WHICH HAS A NON-FIXED PAYMENT PAYABLE AT THE DISCRETION OF THE CEO AND IN THE CASE OF THE CEO, THE BOARD OF TRUSTEES. THE MAXIMUM NON-FIXED PORTION OF THESE INCENTIVE PAYMENTS IS BETWEEN 8% (CEO - 40% MAX, OF THAT 32% TEAM, 8% INDIVIDUAL) AND 4% (SVP - 20% MAX, OF THAT 16% TEAM AND 4% INDIVIDUAL; VP - 10% MAX, OF THAT 6% TEAM AND 4% INDIVIDUAL; AND (EVP - 30% MAX, OF THAT 24% TEAM AND 6% INDIVIDUAL).

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (4 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd	CUSIPCUSIPNum
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
A	043431814	2025-08-04	$92,500,000	THE BOND ISSUE WAS USED TO REFUND SERIES L-1 BONDS ISSUED ON 8/3/2015	false	false	false
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
B	043431814	2016-06-23	$281,786,480	(SEE STATEMENT)	false	false	false	05758XNZ0
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
C	043431814	2019-09-03	$60,255,238	THE BOND ISSUE WAS USED TO REFUND SERIES K BONDS ISSUED ON 5/22/2008.	false	false	false	57584YVC0
MASSACHUSETTS DEVELOPMENT FINANCE AGENCY
D	043431814	2021-07-28	$57,500,000	THE BOND ISSUE WAS USED TO REFUND SERIES L-2A BONDS ISSUED ON 7/2/2012.	false	false	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (4 entries)

Bond ReferenceBondReferenceCd	Total ProceedsTotalProceedsAmt	Other Spent ProceedsOtherSpentProceedsAmt	Substantial CompletionSubstantialCompletionYr	Refunding Tax Exempt BondsRefundingTaxExemptBondsInd	Refunding Taxable BondsRefundingTaxableBondsInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd	Capitalized InterestCapitalizedInterestAmt	Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt	Capital ExpendituresCapitalExpendituresAmt
A	$92,500,000	$92,500,000	2025	Yes (true)	false	Yes (true)	Yes (true)
B	$282,914,006		2019	false	false	Yes (true)	Yes (true)	$1,127,526	$2,486,701	$279,299,779
C	$60,255,238	$59,091,281	2019	Yes (true)	false	Yes (true)	Yes (true)		$1,163,957
D	$57,500,000	$57,500,000	2021	Yes (true)	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (4 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Engage Bond Counsel ContractsEngageBondCounselContractsInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Remedial Action TakenRemedialActionTakenInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	false	Yes (true)
B	false	false	false	false	Yes (true)	Yes (true)	false	false	false	Yes (true)
C	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	false	Yes (true)
D	false	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	false	false	false	Yes (true)

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (4 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Rebate Not Due YetRebateNotDueYetInd	Exception To RebateExceptionToRebateInd	No Rebate DueNoRebateDueInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Term Of HedgeTermOfHedgePct	Superintegrated HedgeSuperintegratedHedgeInd	Hedge TerminatedHedgeTerminatedInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Term Of GICTermOfGICPct	Regulatory Safe Harbor StsfdRegulatorySafeHarborStsfdInd	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd
MORGAN STANLEY CAPITAL SERVICES INC
A	false	false	Yes (true)	false	Yes (true)	Yes (true)	39.8	false	false	false	0	false	false	Yes (true)
(no name)
B	false	false	false	Yes (true)	false	false	0	false	false	false	0	false	false	Yes (true)
(no name)
C	false	false	false	Yes (true)	false	false	0	false	false	false	0	false	false	Yes (true)
MORGAN STANLEY CAPITAL SERVICES INC
D	false	false	Yes (true)	false	Yes (true)	Yes (true)	39.8	false	false	false	0	false	false	Yes (true)

Procedures Corrective Action ProceduresCorrectiveActionGrp (4 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	Yes (true)
B	Yes (true)
C	Yes (true)
D	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule K, Part I, Column (f) B (F) DESCRIPTION OF PURPOSE	THE BOND ISSUE WAS USED TO PARTIALLY COVER THE ACQUISITION AND FIT-OUT OF RESEARCH SPACE AND VIVARIUM AT THE LONGWOOD CENTER; TO PARTIALLY COVER THE REPLACEMENT OF HVAC SYSTEM AT THE SMITH BUILDING; TO COVER THE RELOCATION TO, RECONSTRUCTION AND EQUIPPING OF THE INSTITUTE'S CELL MANIPULATION CORE FACILITY; AND TO COVER THE COSTS OF BOND ISSUANCE AND INTEREST DURING THE CONSTRUCTION PERIOD AS WELL AS OTHER CAPITAL PROJECTS.
Schedule K, Part II (PROCEEDS)	B 3 THE TOTAL PROCEEDS OF $282,914,006 INCLUDE INVESTMENT EARNINGS IN THE AMOUNT OF $1,127,526.
Schedule K, Part IV SCHEDULE K, PART IV (ARBITRAGE)	A 2(c) This issuance was refunded in 2025 and had no invested assets and qualifies for 6-month spending exception. D 2(b) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception. E 2(b) This issuance was refunded in 2021 and had no invested assets and qualifies for 6-month spending exception.
Schedule K, Part IV, Line 2c COLUMN B	Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020
Schedule K, Part IV, Line 2c COLUMN C	Issuer name: MASSACHUSETTS DEVELOPMENT FINANCE AGENCY The calculation for computing no rebate due was performed on 11/01/2020

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	MASSACHUSETTS DEVELOPMENT FINANCE AGENCY	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Bond Issuer EIN	043431814	BondIssuerEIN
Bond Issued	2021-07-28	BondIssuedDt
Issue Price	$35,000,000	IssuePriceAmt
Purpose	THE BOND ISSUE WAS USED TO REFUND SERIES L-2B BONDS ISSUED ON 7/2/2012.	PurposeDesc
Defeased	false	DefeasedInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Pool Financing	false	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Total Proceeds	$35,000,000	TotalProceedsAmt
Other Spent Proceeds	$35,000,000	OtherSpentProceedsAmt
Substantial Completion	2021	SubstantialCompletionYr
Refunding Tax Exempt Bonds	Yes (true)	RefundingTaxExemptBondsInd
Refunding Taxable Bonds	false	RefundingTaxableBondsInd
Final Allocation Made	Yes (true)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (true)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	false	OwningBondFinancedPropertyInd
Any Lease Arrangements	false	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (true)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (true)	EngageBondCounselContractsInd
Any Research Agreements	Yes (true)	AnyResearchAgreementsInd
Engage Bond Counsel Research	Yes (true)	EngageBondCounselResearchInd
Private Bus Use By Others	0.0	PrivateBusUseByOthersPct
Private Bus Concerning UBI	0.0	PrivateBusConcerningUBIPct
Total Private Business Use	0.0	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	false	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	false	ChangeInUseBondFinancedPropInd
Change In Use Bond Financed Prop	0	ChangeInUseBondFinancedPropPct
Remedial Action Taken	false	RemedialActionTakenInd
Procs Nonqualified Bond Remdtd	Yes (true)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	false	Form8038TFiledInd
Rebate Not Due Yet	false	RebateNotDueYetInd
Exception To Rebate	Yes (true)	ExceptionToRebateInd
No Rebate Due	false	NoRebateDueInd
Variable Rate Issue	Yes (true)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (true)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	MORGAN STANLEY CAPITAL SERVICES INC	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Term Of Hedge	39.8	TermOfHedgePct
Superintegrated Hedge	false	SuperintegratedHedgeInd
Hedge Terminated	false	HedgeTerminatedInd
Gross Proceeds Invested In GIC	false	GrossProceedsInvestedInGICInd
Term Of GIC	0	TermOfGICPct
Regulatory Safe Harbor Stsfd	false	RegulatorySafeHarborStsfdInd
Gross Proceeds Invested	false	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (true)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (true)	ProceduresCorrectiveActionInd

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (7 entries)

Relationship With OrgRelationshipWithOrgTxt	Loan PurposeLoanPurposeTxt	Loan From OrganizationLoanFromOrganizationInd	Original PrincipalOriginalPrincipalAmt	Balance DueBalanceDueAmt	DefaultDefaultInd	Board Or Committee ApprovalBoardOrCommitteeApprovalInd	Written AgreementWrittenAgreementInd
Duval Melany
Employee	Housing Loan	Yes (X)	$150,000	$48,750	false	Yes (true)	Yes (true)
Ebert Benjamin
Employee	Tuition Assistance	Yes (X)	$210,482	$189,566	false	Yes (true)	Yes (true)
Hahn William
Employee	Tuition Assistance	Yes (X)	$128,074	$120,282	false	Yes (true)	Yes (true)
Haigis Kevin
Employee	Housing Loan	Yes (X)	$100,000	$45,834	false	Yes (true)	Yes (true)
Haigis Kevin
Employee	Tuition Assistance	Yes (X)	$46,482	$43,202	false	Yes (true)	Yes (true)
McCormick Patrick
Employee	Housing Loan	Yes (X)	$300,000	$291,667	false	Yes (true)	Yes (true)
Willcox Jennifer
Employee	Tuition Assistance	Yes (X)	$226,121	$211,717	false	Yes (true)	Yes (true)

Field	Value	IRS element (for citing)
Total Balance Due	$951,018	TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Clothing And Household Goods ClothingAndHouseholdGoodsGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Noncash Contributions Rpt F990	$1,650,000	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Market value	MethodOfDeterminingRevenuesTxt

Cars And Other Vehicles CarsAndOtherVehiclesGrp

Field	Value	IRS element (for citing)
Contribution	42	ContributionCnt
Noncash Contributions Rpt F990	$49,695	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Market value	MethodOfDeterminingRevenuesTxt

Securities Closely Held Stock SecuritiesCloselyHeldStockGrp

Field	Value	IRS element (for citing)
Contribution	257	ContributionCnt
Noncash Contributions Rpt F990	$28,187,072	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Market value	MethodOfDeterminingRevenuesTxt

Food Inventory FoodInventoryGrp

Field	Value	IRS element (for citing)
Contribution	11	ContributionCnt
Noncash Contributions Rpt F990	$200,497	NoncashContributionsRptF990Amt
Method Of Determining Revenues	Market value	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp (2 entries)

Non Cash CheckboxNonCashCheckboxInd	DescDesc	ContributionContributionCnt	Noncash Contributions Rpt F990NoncashContributionsRptF990Amt	Method Of Determining RevenuesMethodOfDeterminingRevenuesTxt
Yes (X)	EVENT TICKETS	7	$970,667	Market value
Yes (X)	MISCELLANEOUS	2	$81,484	Market value

Field	Value	IRS element (for citing)
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	Yes (true)	ReviewProcessUnusualNCGiftsInd
Third Parties Used	Yes (true)	ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Schedule M, Part I COLUMN (B)	DANA-FARBER CANCER INSTITUTE, INC. (DFCI) IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED.
Schedule M, Part I, Line 32b Third parties used to solicit, process, or sell noncash contributions	DFCI HAS AN ARRANGEMENT WITH ANOTHER CHARITY PURSUANT TO WHICH THE OTHER CHARITY ACCEPTS CERTAIN NONCASH DONATIONS FOR THE BENEFIT OF DANA-FARBER. PROCEEDS FROM THE SALE OF NONCASH DONATIONS ARE DIRECTED TO A DESIGNATED FUND FOR THE BENEFIT OF DANA-FARBER. IN ADDITION, DANA-FARBER HAS AN ARRANGEMENT WITH ANOTHER CHARITY PURSUANT TO WHICH THE OTHER CHARITY PROCESSES VEHICLE DONATIONS FOR THE BENEFIT OF DANA-FARBER. PROCEEDS FROM THE SALE OF DONATED VEHICLES ARE DIRECTED TO DANA-FARBER.
Schedule M, Part I, Line 33 Noncash contribution amounts not reported	DFCI RECEIVED DONATIONS OF ART, BOOKS, AND OTHER GOODS THAT IT DISPLAYS IN ITS PROPERTIES. THESE GOODS HAVE VALUES THAT ARE EITHER NOMINAL OR ARE NOT READILY DETERMINABLE AND ARE, THEREFORE, NOT INCLUDED AS REVENUE.

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (14 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
Form 990, Part I, Line 1 Organization's mission	THE MISSION OF DANA-FARBER CANCER INSTITUTE (DFCI) IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED.
Form 990, Part III, Line 1 Organization's mission	THE MISSION OF DFCI IS TO PROVIDE EXPERT, COMPASSIONATE, AND EQUITABLE CARE TO CHILDREN, ADULTS, AND THEIR FAMILIES, WHILE ADVANCING THE UNDERSTANDING, DIAGNOSIS, TREATMENT, CURE, AND PREVENTION OF CANCER AND RELATED DISEASES. WE TRAIN NEW GENERATIONS OF CLINICIANS AND SCIENTISTS, DISSEMINATE INNOVATIVE PATIENT THERAPIES AND SCIENTIFIC DISCOVERIES AROUND THE WORLD, AND REDUCE THE IMPACT OF CANCER, WHILE AT ALL TIMES MAINTAINING A FOCUS ON THOSE COMMUNITIES THAT HAVE BEEN HISTORICALLY MARGINALIZED.
Form 990, Part III, Line 4a Program Service Accomplishments	CLINICAL CARE AS ONE OF THE LEADING CANCER CENTERS IN THE WORLD, DANA-FARBER CANCER INSTITUTE PROVIDES COMPASSIONATE, COMPREHENSIVE, AND PERSONALIZED CARE TO ADULTS AND CHILDREN WITH CANCER, BLOOD DISORDERS, AND RELATED DISEASES. IN FISCAL YEAR 2025, OUR EXPERT CLINICIANS AND CAREGIVERS AT OUR SPECIALIZED TREATMENT CENTERS WORKED TOGETHER TO DELIVER THE LATEST THERAPIES TO OUR PATIENTS THROUGH 1,295 INPATIENT ADMISSIONS, 417,867 OUTPATIENT DOCTOR VISITS, AND 242,140 INFUSION TREATMENTS. SINCE ITS FOUNDING IN 1947 BY SIDNEY FARBER, MD, DANA-FARBER HAS FOLLOWED HIS VISION FOR A CANCER CENTER THAT IS JUST AS DEDICATED TO DISCOVERIES IN CANCER RESEARCH AS IT IS TO DELIVERING EXPERT, COMPASSIONATE CARE. OUR INSTITUTE IS A FOUNDING MEMBER OF DANA-FARBER/HARVARD CANCER CENTER AND ONE OF 57 NCI-DESIGNATED COMPREHENSIVE CANCER CENTERS IN THE U.S. WE ARE THE ONLY HOSPITAL RANKED IN THE TOP THREE NATIONALLY BY U.S. NEWS AND WORLD REPORT IN BOTH ADULT AND PEDIATRIC CANCER CARE. IN 2025, WE OFFERED MORE THAN 1,200 CLINICAL TRIALS
Form 990, Part III, Line 4b Program Service Accomplishments	RESEARCH Scientific work at Dana-Farber is based on the premise that basic and clinical investigation are complementary and reinforcing activities. To encourage this cross-pollination of ideas, the institute has developed an organizational framework that fosters collaborations among investigators from different disciplines. The result is an intense scientific impact on a group of diseases that continue to represent one of humanity's greatest health challenges. Some recent advances include: Belzutifan approved by US Food and Drug Administration (FDA) for kidney cancer: in a large phase 3 multicenter clinical trial, patients with metastatic clear cell renal cell carcinoma who received belzutifan had better survival outcomes than those who received standard therapy. Cabozantinib approved by us FDA for neuroendocrine tumors of the pancreas or elsewhere: in a phase 3 clinical trial, patients with previously treated, advanced disease who received cabozantinib had better survival outcomes than those who received a placebo. Dordaviprone was granted accelerated approval by us FDA for patients with recurrent rare fatal brain cancer: in a phase 2 clinical trial, dordaviprone, an oral, first in class targeted medicine, was well tolerated by patients with recurrent h3 k27m-mutant diffuse midline glioma and provided a durable response for some patients. Pembrolizumab approved by us FDA as up-front treatment for head and neck cancer: in a pivotal phase 3 trial, patients who received pembrolizumab before, during, and after steadard care had better survival outcomes than those who received standard care alone. Ruvemenib approved by us FDA for relapsed or refractory acute myeloid leukemia with common mutations: revumenib is a first-in-class oral menin inhibitor that was approved for the treatment of patients with kmt2a translocations in 2024. The 2025 approval was based on results of a phase 2 clinical trial for patients with npm1 mutations, giving up to 40% of patients with AML access to this medicine. Sunvozertinib approved by us FDA for egfr-mutated non-small cell lung cancer: in a phase 2 clinical trial, sunvozertinib showed positive results for patients with previously treated advanced non-small cell lung cancer with certain EGFR mutations. Antibody-drug conjugate (ADC) shows promise as first-line therapy for patients with advanced triple negative breast cancer who are not eligible for immunotherapy: a phase 3 clinical trial reported early results suggesting that patients who received sacituzumab govitecan had improved progression-free survival compared to patients receiving standard chemotherapy. Adc combination shows promise for metastatic her2-positive breast cancer: a phase 3 trial reported improved progression-free survival for patients receiving a combination of trastuzumab deruxtecan plus pertuzumab compared to current standard first line therapy. Ras inhibitor shows promise in advanced pancreatic cancer: early results of a phase 1/2 clinical trial supported the initiation of a phase 3 study comparing daraxonrasib to second line chemotherapy for patients with advanced pancreatic cancer. Personalized cancer vaccines continue to be improved and tested: early phase clinical trials reported promising results in kidney cancer and in melanoma. Natural killer (NK) cell therapies continue to be designed and tested: a new clinical trial testing NK cell therapies has begun in ovarian cancer. Direct cyclin inhibitors: direct cyclin inhibitors are a new class of medicine that disables a quality control checkpoint in the cell cycle. Laboratory evidence supported the launch of a nationwide phase 1 clinical trial of a first-in-class direct cyclin inhibitor for patients with small cell lung cancer, triple negative breast cancer and other cancers. Weight-loss intervention validated: clinical trials can now proceed to determine if weight loss through use of the validated intervention can help reduce the risk of breast cancer recurrence. Exercise and diet influence survival: clinical studies reported that after treatment for colorectal cancer, exercise and anti-inflammatory diets can improve survival. Acute leukemia diagnostic: a new diagnostic tool for acute leukemia could significantly improve patient care by allowing faster and more precise treatment decisions. Multiple myeloma blood test: a novel blood test for multiple myeloma enables diagnosis of multiple myeloma and its precursors using a blood test, offering an alternative to traditional bone marrow biopsy.
Form 990, Part III, Line 4c Program service accomplishments	COMMUNITY HEALTH The role of Dana-Farber's Community Health office is to support the Institute's goal to reduce cancer risk among medically underserved populations. We work with city and state health departments, community partners, and Boston-based coalitions to assess and monitor the needs of local residents with respect to cancer control. In collaboration with staff throughout Dana-Farber, we serve as a bridge with community organizations and establish evidence-based and sustainable outreach programs. We are on the front lines of supporting and collaborating on programs designed to eliminate disparities in breast, colon, and skin cancer; educate diverse populations about tobacco cessation, human papillomavirus (HPV) prevention and screening; and strengthen the support system for medically underserved populations. In short, we are committed to making Dana-Farber's care and research findings more accessible to everyone within and outside its walls. FY25 programmatic highlights are as follows: Dana-Farber's mammography services provided 2,836 mammograms on the van and at the mammography suite at Whittier Street Health Center in Roxbury. Dana-Farber's Sun Safety Program provided 16 in-person sun safety screening events with added health and safety measures. 860 participants were screened by a dermatologist and 123 people were referred for follow-up appointments. 52 participants were referred for a biopsy. Dana-Farber's Tobacco Treatment program received 28 referrals and provided 35 individual tobacco cessation counseling sessions to 13 patients. 9 participants were able to reduce their total number of cigarettes smoked per day, and 4 of these reported being able to quit completely. The Tobacco Treatment program continued to provide financial incentives for participants enrolled in the program. Stop and Shop gift cards were provided after counseling sessions to encourage individuals to reduce their tobacco usage and quit smoking. Continued to partner with the Breast Oncology Department in managing AssessYourRisk, a digital tool to help people of all ages better understand and manage their risk of breast and ovarian cancer. The survey tool was completed by over 10,000 users in FY25. Implemented and evaluated the fourth and final year of Dana-Farber's multi-year Systems Level Funding, awarded to three non-profit organizations in Greater Boston to address air quality, environmental justice, and child homelessness. Successes from the fourth year include advancing air quality legislation, launching community-owned data tools, strengthening cross-sector partnerships, and deepening resident and youth leadership - building momentum for continued policy, systems, and environmental (PSE) change beyond the grant-funded period. The Education and Outreach team held 65 events in 5 languages (English, Cantonese, Haitian-Creole, Mandarin, and Spanish), reaching a total of 4,868 participants. These events included cancer education sessions on topics including General Cancer Prevention & Resources, HPV-Related Cancer, Breast Cancer, and Colorectal Cancer, and Prostate Cancer, as well as community events including tabling at health fairs, farmers markets, and cultural celebrations such as Lunar New Year and Pride for the People, where we provide tailored education materials and speak to community members in our priority populations about cancer prevention. The Education and Outreach team expanded outreach in bilingual media, specifically for Spanish speaking and Chinese populations. In FY25, we published 44 posts in Simplified and Traditional Chinese on WeChat, a social media platform popular among Chinese populations. We also participated in 4 interviews on Spanish media platforms (Telemundo, Univision, La Mega Radio, Orale con Veronica) focused on breast and colorectal cancer screening. Lastly, we published 4 articles in Spanish in El Mundo newspaper. From late 2024 through early 2025, Dana-Farber's Community Health Office, in collaboration with the Community Benefits External/Determination of Need (DoN) Advisory Committee, conducted a series of community information sessions to solicit public input related to planning for Dana-Farber's proposed inpatient adult cancer hospital.
Form 990, Part VI, Line 2 Family/business relationships amongst interested persons	ANDREW JANOWER AND MICHAEL EISENSON - Business relationship, JOSH BEKENSTEIN, ANDREW KAPLAN, AND NANCY LOTANE - Business relationship, RICHARD LUBIN, CHRISTOPHER HADLEY, AND JANE BROCK-WILSON - Business relationship, SUSHIL TULI AND PETER PALANDJIAN - Business relationship, BRIAN KNEZ AND JESSICA KNEZ DULAC - Family relationship
Form 990, Part VI, Line 11b Review of form 990 by governing body	THE DFCI'S TAX DEPARTMENT PROVIDES ALL FINANCIAL ANALYSIS AND OTHER INFORMATION TO BE INCLUDED ON THE TAX RETURN TO ITS EXTERNAL TAX PREPARER, ERNST & YOUNG LLP, WHICH PREPARES THE DRAFT RETURN. THE DRAFT RETURN IS THEN REVIEWED BY THE DFCI'S TAX MANAGER, AS WELL AS THE DFCI'S OFFICE OF GENERAL COUNSEL AND SENIOR MANAGEMENT, BEFORE IT IS SUBMITTED FOR AUDIT COMMITTEE REVIEW. AFTER THE AUDIT COMMITTEE REVIEWS THE TAX RETURN, AN ELECTRONIC MESSAGE IS SENT TO ALL GOVERNING BOARD MEMBERS WITH A SECURE LINK TO THE TAX RETURN. THE BOARD HAS THE OPPORTUNITY TO REVIEW THE RETURN AND BRING ANY ISSUES TO THE ATTENTION OF THE APPROPRIATE EXECUTIVE MANAGEMENT INDIVIDUALS. A FINAL VERSION OF THE FORM IS APPROVED BY THE CFO AND FILED ELECTRONICALLY BY ERNST & YOUNG LLP WITH THE IRS.
Form 990, Part VI, Line 12c Conflict of interest policy	DFCI MONITORS AND ENFORCES COMPLIANCE WITH THE DFCI CONFLICT OF INTEREST AND CONFIDENTIALITY POLICY FOR BOARD OFFICERS, TRUSTEES, AND KEY EMPLOYEES ("COVERED PERSONS"). THE OFFICE OF GENERAL COUNSEL ANNUALLY DISTRIBUTES A CONFLICT OF INTEREST QUESTIONNAIRE AND CONFIDENTIALITY STATEMENT ("STATEMENT") REQUIRING ALL COVERED PERSONS TO DISCLOSE INTERESTS, ROLES, AND ACTIVITIES THAT COULD GIVE RISE TO A POTENTIAL OR ACTUAL CONFLICT WITH THE INTERESTS OF DFCI. IF A TRUSTEE FAILS TO COMPLETE THE ANNUAL STATEMENT, THE CHAIR OF THE GOVERNANCE COMMITTEE MAY TAKE ACTIONS TO SUSPEND THE TRUSTEE. ADDITIONALLY, DFCI REQUIRES COVERED PERSONS TO COMPLETE THE STATEMENT UPON INITIAL APPOINTMENT TO A COVERED OFFICE AND TO UPDATE THEIR DISCLOSURES ON A CONTINUING BASIS WHENEVER A COVERED PERSON BECOMES AWARE OF A NEW OR PREVIOUSLY UNDISCLOSED INTEREST. THE OFFICE OF GENERAL COUNSEL COMPARES THE DISCLOSURES TO INSTITUTIONAL INFORMATION IN ORDER TO IDENTIFY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. THE DFCI GENERAL COUNSEL REPORTS ON ALL DISCLOSURES TO THE PRESIDENT OF DFCI, CHAIR OF THE DFCI BOARD AND CHAIR OF THE DFCI BOARD GOVERNANCE COMMITTEE. THE BOARD IS RESPONSIBLE UNDER THE COI POLICY FOR ADDRESSING ISSUES RELATED TO CONFLICTS OF COVERED PERSONS. A PROPOSED ARRANGEMENT CREATING A CONFLICT OF INTEREST MAY BE APPROVED IF APPROPRIATE STEPS ARE TAKEN TO ENSURE THAT DFCI MAKES A DECISION IN AN OBJECTIVE AND FAIR MANNER CONSISTENT WITH THE HIGHEST ETHICAL AND LEGAL STANDARDS. SUCH STEPS INCLUDE RECUSAL OF THE COVERED PERSON WITH A CONFLICT OF INTEREST FROM NEGOTIATIONS OR DISCUSSIONS ON BEHALF OF DFCI OR THE ENTITY WITH WHICH DFCI IS DOING BUSINESS AND FROM BOARD OR DFCI MANAGEMENT DISCUSSIONS OF SUCH ARRANGEMENT.
Form 990, Part VI, Line 15a Process to establish compensation of top management official	PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES REVIEWS THE PRESIDENT'S (DFCI'S CHIEF EXECUTIVE OFFICER) PERFORMANCE AND MAKES A RECOMMENDATION REGARDING COMPENSATION TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE ACTS ON THE RECOMMENDATION. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE COMPENSATION COMMITTEE ANNUALLY COMMISSIONS AN INDEPENDENT REVIEW BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT TO COMPARE SUCH COMPENSATION WITH THAT OF OTHER SIMILARLY SITUATED INDIVIDUALS IN THE HEALTHCARE FIELD IN AND OUTSIDE OF THE REGION. THE DECISION OF THE EXECUTIVE COMMITTEE IS REPORTED TO THE FULL BOARD. THE BOARD COMPLETED THIS PROCESS AS OF JANUARY 2024.
Form 990, Part VI, Line 15b Process to establish compensation of other employees	PROCESS FOR DETERMINING COMPENSATION OF OFFICERS AND KEY EMPLOYEES PER DFCI'S EXECUTIVE COMPENSATION PHILOSOPHY, ANNUALLY THE DFCI PRESIDENT REVIEWS THE PERFORMANCE OF OFFICERS AND KEY EMPLOYEES. THE PRESIDENT MAKES A RECOMMENDATION AS TO THE COMPENSATION OF THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES COMPENSATION FOR THOSE INDIVIDUALS BASED ON THAT RECOMMENDATION. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HIS DETERMINATION OF COMPENSATION FOR THOSE INDIVIDUALS. TO ENSURE COMPLIANCE WITH THE PHILOSOPHY, THE PRESIDENT AND COMPENSATION COMMITTEE ANNUALLY RECEIVE A REPORT BY A THIRD-PARTY EXECUTIVE COMPENSATION CONSULTANT. THE REPORT ANALYZES THE COMPETITIVENESS OF THE TOTAL COMPENSATION PROGRAM FOR DISQUALIFIED PERSONS AGAINST MARKET DATA REPRESENTING DFCI'S LOCAL AND NATIONAL PEER ORGANIZATIONS. THE PRESIDENT MAKES RECOMMENDATIONS FOR MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS WHO ARE DISQUALIFIED PERSONS OF DFCI TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. THE COMPENSATION COMMITTEE APPROVES MARKET ADJUSTMENTS FOR THOSE INDIVIDUALS BASED ON THE PRESIDENT'S RECOMMENDATION. THE BOARD COMPLETED THIS PROCESS AS OF JUNE 2024. FOR KEY EMPLOYEES WHO ARE NOT DISQUALIFIED PERSONS, THE PRESIDENT REPORTS TO THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES ON HER DETERMINATION OF MARKET ADJUSTMENTS AS NEEDED FOR THOSE INDIVIDUALS.
Form 990, Part VI, Line 19 Required documents available to the public	GOVERNING DOCUMENTS: THE GOVERNING DOCUMENTS ARE AVAILABLE UPON REQUEST. THESE DOCUMENTS ARE ALSO AVAILABLE TO THE PUBLIC ON THE SECRETARY OF THE COMMONWEALTH'S WEBSITE. CONFLICT OF INTEREST POLICY: DFCI'S BOARD OF TRUSTEES CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS: THE ORGANIZATION USES THE SERVICES OF DIGITAL ASSURANCE CERTIFICATION LLC (DAC) TO REPORT ANNUAL AUDITED FINANCIAL STATEMENTS AND OTHER RELEVANT ORGANIZATIONAL INFORMATION AS REQUIRED BY CERTAIN REGULATORY AND TAX LAWS. DAC IS A WEBSITE (WWW.DACBOND.COM) FREE TO THE PUBLIC THAT PUBLISHES TAX-EXEMPT BOND ISSUERS' FINANCIAL AND LEGAL DOCUMENTS SUCH AS THE AUDITED FINANCIAL STATEMENTS. FISCAL YEAR 2016 THROUGH THE LATEST ISSUE DATE OF THE AUDITED FINANCIAL STATEMENTS FOR DANA-FARBER CANCER INSTITUTE, INC. CAN BE FOUND ON THE DAC WEBSITE. ANNUAL AUDITED FINANCIAL STATEMENTS FROM FISCAL YEAR 1998 THROUGH FISCAL YEAR 2015 ARE AVAILABLE UPON REQUEST.
Form 990, Part VII, Section B, Line 1 INDEPENDENT CONTRACTORS	THE AMOUNT PAID TO WALSH BROTHERS, INC. INCLUDED COSTS FOR BUILDING SERVICES AND MATERIALS. HOWEVER, THE ORGANIZATION WAS UNABLE TO OBTAIN INFORMATION TO BREAKOUT THE EXACT AMOUNT FOR MATERIAL COSTS.
Form 990, Part VIII, Line 11d Other Miscellaneous Revenue	All Other - Total Revenue: 4177938, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: 4177938;
Form 990, Part XI, Line 9 Other changes in net assets or fund balances	CHANGE IN INTEREST IN ASSETS HELD BY AFFILIATES - XXX-XX-XXXX; CHANGE IN VALUE OF SWAP AGREEMENT - 23437757; PENSION ADJUSTMENT - -59494; Total - XXX-XX-XXXX;

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt
DANA-FARBER GLOBAL ONCOLOGY LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	851914853	INTERNATIONAL ONCOLOGY	MA	$1,970,857	$11,359,146	DFCI
BINNEY STREET CAPITAL FUND LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215		INVESTMENTS	DE	-$723,743	$7,339,663	DFI
Dana-Farber National Workforce LLC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	921748999	Professional employer organization	MA	$0	$0	DFCI

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (7 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Exempt Code SectionExemptCodeSectionTxt	Public Charity StatusPublicCharityStatusTxt	Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt	Controlled OrganizationControlledOrganizationInd
DANA-FARBER INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043102433	INVESTMENT MANAGEMENT	MA	501(c)(3)	Type I	DFCI	Yes (true)
THE DANA-FARBER TRUST INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	300195757	RECEIVE REAL ESTATE GIFTS FOR DFCI	MA	501(c)(3)	Type I	DFCI	Yes (true)
DANA-FARBERMASS GEN BRIGHAM CANCER CARE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043320640	ONCOLOGY RESEARCH	MA	501(c)(3)	Type I	NA	false
RMSA TRUST
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	562656539	VEBA TRUST	MA	501(c)(9)		DFCI	Yes (true)
FRIENDS OF DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	371613621	FUNDRAISING	MA	501(c)(3)	Type I	DFCI	Yes (true)
DANA-FARBERCHILDREN'S HOSP CANCER CARE
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	043554536	PEDIATRIC ONCOLOGY	MA	501(c)(3)	Type I	NA	false
DANA-FARBER CANCER CARE NETWORK INC
450 BROOKLINE AVENUE	BP418	BOSTON	MA	02215	465138314	ONCOLOGY CARE	MA	501(c)(3)	10	DFCI	Yes (true)

Id Related Org Txbl Partnership IdRelatedOrgTxblPartnershipGrp

Related Organization Name RelatedOrganizationName

Field	Value	IRS element (for citing)
Business Name Line1	MGB DF INTL LLC	BusinessNameLine1Txt

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	399 REVOLUTION DR	AddressLine1Txt
Address Line2	STE 645	AddressLine2Txt
City	SOMERVILLE	CityNm
State Abbreviation	MA	StateAbbreviationCd
ZIP	02145	ZIPCd

Field	Value	IRS element (for citing)
EIN	871595882	EIN
Primary Activities	INTERNATIONAL CONSULTING	PrimaryActivitiesTxt
Legal Domicile State	DE	LegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

Field	Value	IRS element (for citing)
Business Name Line1	NA	BusinessNameLine1Txt

Field	Value	IRS element (for citing)
Predominant Income Type	N/A	PredominantIncomeTypeTxt
Share Of Total Income	-$23,251	ShareOfTotalIncomeAmt
Share Of EOY Assets	-$167,361	ShareOfEOYAssetsAmt
Disproportionate Allocations	false	DisproportionateAllocationsInd
General Or Managing Partner	false	GeneralOrManagingPartnerInd
Ownership	0.5	OwnershipPct

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	false	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	false	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (true)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	false	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	false	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	false	DivRelatedOrganizationInd
Asset Sale To Other Org	false	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	false	AssetPurchaseFromOtherOrgInd
Asset Exchange	false	AssetExchangeInd
Rental Of Facilities To Oth Org	false	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	false	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	false	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	false	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	false	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (true)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	false	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	false	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	Yes (true)	TransferToOtherOrgInd
Transfer From Other Org	Yes (true)	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (6 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
Dana-Farber Inc
R	$105,918,323	Cash
Dana-Farber Inc
S	$465,246,292	Cash
Friends of Dana-Farber Cancer Institute Inc
C	$1,340,898	Cash
Friends of Dana-Farber Cancer Institute Inc
O	$323,495	Actual Exp
RMSA Trust
R	$820,889	Cash
Dana-Farber Cancer Care Network Inc
S	$1,522,980	Cash